Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3009340	s-metnor	— (—)	4750	6210	100.00%	Distribution not available
3009340	s-metnor	nmol/l (nmol/l)	772	999	99.90%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Benign neoplasm: Adrenal gland

1098

308

53.82

307.65

1.4

1.3

—

nmol/l

—

Secondary hypertension

306

179

18.23

307.65

1.4

1.3

—

nmol/l

—

Benign neoplasm of other and unspecified endocrine glands

1225

549

27.91

307.65

1.5

1.3

—

nmol/l

—

Headache

1025

2457

3.28

244.03

1.3

—

nmol/l

—

Hyperaldosteronism

180

21.81

231.77

1.3

1.2

—

nmol/l

—

Other heart diseases

635

942

4.46

217.45

1.3

—

nmol/l

—

Other disorders of fluid, electrolyte and acid-base balance

568

1412

3.88

183.55

1.3

—

nmol/l

—

Abnormalities of breathing

1139

2420

2.72

181.51

1.3

—

nmol/l

—

Cardiac arrhythmias

827

1683

3.20

179.27

1.3

—

nmol/l

—

Malignant neoplasm of adrenal gland, including Hilmo

113

46.69

177.20

4.7

1.4

—

nmol/l

—

Other disorders of adrenal gland

172

170

11.03

155.51

3.3

1.2

—

nmol/l

—

Malignant neoplasm of adrenal gland

69.26

150.45

5.0

1.4

—

nmol/l

—

Anaemias

263

230

7.45

146.97

1.4

1.3

—

nmol/l

—

Hyperhidrosis

142

115

13.57

146.49

1.2

1.3

—

nmol/l

—

Medical observation and evaluation for suspected diseases and conditions

824

1488

2.86

138.57

1.4

1.3

—

nmol/l

—

Cerebrovascular diseases (FINNGEN)

393

631

4.44

138.30

1.5

1.2

—

nmol/l

—

Hypokalaemia

271

539

5.23

128.81

1.2

1.3

—

nmol/l

—

Hypothyroidism (congenital or acquired)

272

236

6.54

127.77

1.4

1.3

—

nmol/l

—

Hypothyroidism, levothyroxine purchases

271

236

6.52

127.11

1.4

1.3

—

nmol/l

—

Hypothyroidism and >3 levothyroxin purchases

271

236

6.52

127.11

1.4

1.3

—

nmol/l

—

Hypertensive heart and/or renal disease

335

545

4.57

123.97

1.4

1.3

—

nmol/l

—

Adrenomedullary hyperfunction

129.29

121.88

6.4

1.1

—

nmol/l

—

Heart failure and antihypertensive medication

288

373

5.10

115.00

1.3

—

nmol/l

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

304

462

4.62

111.52

1.3

—

nmol/l

—

Malignant neoplasm of endocrine gland, including Hilmo

217

422

5.41

106.30

3.4

1.3

—

nmol/l

—

Paroxysmal tachycardia

281

534

4.45

105.51

1.3

1.2

—

nmol/l

—

Pain in joint

678

1618

2.60

101.76

1.3

—

nmol/l

—

Atrial fibrillation and flutter

345

583

3.87

99.52

1.3

—

nmol/l

—

Hypertensive Heart Disease

281

506

4.28

97.63

1.3

—

nmol/l

—

Syncope and collapse

545

1692

2.72

96.81

1.3

—

nmol/l

—

Type 2 diabetes, wide definition

953

2811

2.16

95.66

1.4

1.3

—

nmol/l

—

Abnormal blood-pressure reading, without diagnosis

128

166

8.15

93.34

1.2

1.4

—

nmol/l

—

Cushing syndrome

20.50

92.37

1.3

1.2

—

nmol/l

—

Hypothyroidism, drug reimbursement

161

158

7.23

92.02

1.6

1.3

—

nmol/l

—

Nausea and vomiting

376

1186

3.14

89.53

1.3

—

nmol/l

—

Non-invasive ventilation

300

716

3.67

88.43

1.5

1.3

—

nmol/l

—

Pain in limb

953

2934

2.08

87.56

1.3

1.4

—

nmol/l

—

Malignant neoplasm of endocrine gland

185

373

5.21

87.05

3.4

1.3

—

nmol/l

—

Other CVD (FINNGEN)

163

211

6.03

82.38

1.5

1.3

—

nmol/l

—

Low back pain

888

2923

2.07

81.44

1.3

—

nmol/l

—

Fever of other and unknown origin

604

2230

2.37

81.39

1.4

1.3

—

nmol/l

—

Atrial fibrillation and flutter with reimbursement

277

453

3.91

80.32

1.2

1.3

—

nmol/l

—

Dorsalgia

1086

2969

1.95

80.24

1.3

—

nmol/l

—

Disorders of thyroid, IBD co-morbidities

213

321

4.61

78.07

1.2

1.3

—

nmol/l

—

Migraine

599

2019

2.33

76.14

1.2

1.3

—

nmol/l

—

Benign neoplasm: Carotid body

65.61

75.52

4.8

1.2

—

nmol/l

—

Pain, not elsewhere classified

356

1240

2.91

74.91

1.4

1.3

—

nmol/l

—

Spondylopathies

880

2586

2.03

74.38

1.3

—

nmol/l

—

General examination and investigation of persons without complaint and reported diagnosis

650

1487

2.29

71.38

1.3

—

nmol/l

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

333

507

3.32

71.10

1.3

—

nmol/l

—

Persons encountering health services in other circumstances

518

2233

2.32

68.49

1.2

1.3

—

nmol/l

—

Spondylosis

637

2315

2.17

68.48

1.3

—

nmol/l

—

Disorders of parathyroid gland

309

1038

3.00

68.07

1.3

1.2

—

nmol/l

—

Chronic kidney disease

392

1447

2.64

67.99

1.4

1.3

—

nmol/l

—

Asthma, unspecified (mode), excluding more controls

597

1927

2.24

67.73

1.3

—

nmol/l

—

Hyperparathyroidism

273

888

3.11

63.79

1.4

1.2

—

nmol/l

—

Asthma, unspecified (mode)

610

2066

2.15

62.97

1.3

—

nmol/l

—

Hernia of abdominal wall, postoperative

212

598

3.57

62.63

1.4

1.2

—

nmol/l

—

Other specific joint derangements/joint disorders

812

2621

1.95

62.02

1.3

—

nmol/l

—

Oedema, not elsewhere classified

368

1406

2.59

61.54

1.3

—

nmol/l

—

Hypopituitarism

126

250

5.20

60.18

1.4

1.2

—

nmol/l

—

Primary hyperparathyroidism

206

602

3.53

58.91

1.4

1.3

—

nmol/l

—

Hypo-osmolality and hyponatraemia

242

774

3.16

58.54

1.3

—

nmol/l

—

Other special examinations and investigations of persons without complaint or reported diagnosis

622

1488

2.13

57.66

1.3

—

nmol/l

—

Adrenocortical insufficiency

136

6.98

57.36

1.9

1.2

—

nmol/l

—

Symptoms and signs concerning food and fluid intake

158

390

4.14

57.23

1.3

—

nmol/l

—

Intracranial trauma

563

1785

2.15

57.19

1.2

1.4

—

nmol/l

—

Biguanides

1027

3546

1.76

57.04

1.3

—

nmol/l

—

Concussion

500

1770

2.21

56.18

1.2

1.4

—

nmol/l

—

Renal failure

532

2140

2.14

56.16

1.4

1.3

—

nmol/l

—

Sciatica+with lumbago

582

2551

2.04

54.56

1.3

—

nmol/l

—

Hyperlipidaemia, other/unspecified

431

1715

2.28

54.00

1.3

—

nmol/l

—

Ischaemic heart disease, wide definition

822

2833

1.80

49.43

1.4

1.3

—

nmol/l

—

Vocal cord dysfunction

159

382

3.72

48.32

1.5

1.3

—

nmol/l

—

Continuous positive airway pressure

192

495

3.27

47.47

1.2

1.3

—

nmol/l

—

Spinal stenosis

536

1974

2.02

47.32

1.3

—

nmol/l

—

Dysphagia

290

1157

2.54

47.02

1.4

1.3

—

nmol/l

—

Fibromyalgia

158

454

3.57

46.37

1.3

—

nmol/l

—

Other/unspecified dorsalgia

411

1903

2.15

45.60

1.4

1.3

—

nmol/l

—

Infections, IBD-co-morbidities

150

274

3.89

45.38

1.4

1.2

—

nmol/l

—

Hypertensive Renal Disease

9.00

44.19

1.4

1.2

—

nmol/l

—

Migraine without aura

233

864

2.73

43.83

1.3

—

nmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

329

873

2.39

42.50

1.2

1.3

—

nmol/l

—

Migraine with aura

279

1156

2.44

41.69

1.2

1.3

—

nmol/l

—

Major coronary heart disease event excluding revascularizations

599

2147

1.86

40.48

1.4

1.3

—

nmol/l

—

Other symptoms and signs involving the digestive system and abdomen

207

764

2.75

39.43

1.4

1.3

—

nmol/l

—

Cervicalgia

250

1023

2.48

38.55

1.3

—

nmol/l

—

Insulin medication

591

2737

1.80

38.27

1.4

1.3

—

nmol/l

—

Follow-up examination after treatment for conditions other than malignant neoplasms

404

1313

2.06

37.28

1.3

—

nmol/l

—

Malignant neoplasm of urinary organs

138

423

3.34

36.66

1.5

1.3

—

nmol/l

—

Malignant neoplasm of urinary organs, including Hilmo

152

494

3.14

36.61

1.5

1.3

—

nmol/l

—

Disorders of mineral metabolism

125

361

3.55

36.49

1.3

—

nmol/l

—

Abnormal findings on diagnostic imaging of other body structures

202

770

2.67

36.27

1.4

1.3

—

nmol/l

—

Oxycodone

407

1755

2.00

36.26

1.4

1.3

—

nmol/l

—

Malignant neoplasm of kidney, except renal pelvis

127

378

3.44

35.39

1.5

1.3

—

nmol/l

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

138

433

3.26

35.31

1.5

1.3

—

nmol/l

—

Myocardial infarction

477

1769

1.90

35.19

1.4

1.3

—

nmol/l

—

Hypotension

204

796

2.60

34.85

1.5

1.3

—

nmol/l

—

Other CVD

229

944

2.46

34.80

1.5

1.3

—

nmol/l

—

Endocrine disorders, other/unspecified

8.07

34.77

2.4

1.2

—

nmol/l

—

Coronary atherosclerosis

624

2264

1.75

34.66

1.3

—

nmol/l

—

Medullary carcinoma of thyroid gland, including Hilmo

72.71

34.44

2.8

1.3

—

nmol/l

—

Phakomatoses, not elsewhere classified

10.60

34.36

3.8

1.4

—

nmol/l

—

Diaphragmatic hernia

401

2073

1.96

34.34

1.3

—

nmol/l

—

Haemorrhage from respiratory passages

309

1289

2.14

33.30

1.4

1.3

—

nmol/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

348

1733

2.03

33.22

1.2

1.3

—

nmol/l

—

Glucagon-like peptide-1 (GLP-1) analogues

348

1733

2.03

33.22

1.2

1.3

—

nmol/l

—

Cervical disc disorders

368

1868

1.99

33.21

1.3

—

nmol/l

—

Cough

368

1741

1.99

32.85

1.3

—

nmol/l

—

Clear cell adenocarcinoma of kidney

216

4.23

32.62

1.3

—

nmol/l

—

Angina pectoris

538

2027

1.77

31.65

1.3

—

nmol/l

—

Rheumatism, unspecified

182

709

2.61

31.35

1.2

1.3

—

nmol/l

—

Pain in thoracic spine

182

709

2.60

31.27

1.3

—

nmol/l

—

Heart failure and coronary heart disease

398

1450

1.94

31.26

1.3

—

nmol/l

—

Disorders of calcium metabolism

272

3.70

30.48

1.3

—

nmol/l

—

Other endocrine disorders

152

4.65

30.10

2.0

1.2

—

nmol/l

—

Abnormal weight loss

137

471

2.97

30.07

1.3

—

nmol/l

—

Polyarthropathies

624

2403

1.68

30.01

1.2

1.3

—

nmol/l

—

Implicit bacterial Sepsis, including avohilmo

452

2088

1.81

29.97

1.4

1.3

—

nmol/l

—

Other anxiety disorders

475

2285

1.78

29.78

1.3

—

nmol/l

—

Other reaction to severe stress, and adjustment disorders

382

2036

1.89

29.78

1.4

1.3

—

nmol/l

—

Implicit bacterial Sepsis

411

1913

1.86

29.51

1.4

1.3

—

nmol/l

—

Weight loss

143

512

2.85

29.13

1.3

—

nmol/l

—

Genitourinary diseases

491

1369

1.81

29.04

1.3

—

nmol/l

—

Benign neoplasm of colon, rectum, anus and anal canal

631

3280

1.64

29.00

1.4

1.3

—

nmol/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

240

3.82

28.96

1.7

1.3

—

nmol/l

—

Other disorders of urethra and urinary system

677

2925

1.62

28.86

1.3

—

nmol/l

—

Pacemaker

347

1679

1.94

28.79

1.3

—

nmol/l

—

838

3184

1.55

28.38

1.4

1.3

—

nmol/l

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

838

3184

1.55

28.38

1.4

1.3

—

nmol/l

—

Convulsions, not elsewhere classified

214

931

2.29

27.95

1.3

—

nmol/l

—

Paralytic ileus and intestinal obstruction

252

1207

2.11

26.76

1.4

1.3

—

nmol/l

—

Other gastritis (incl. Duodenitis)

232

1078

2.18

26.75

1.3

—

nmol/l

—

Chronic pancreatitis

151

582

2.64

26.65

1.5

1.3

—

nmol/l

—

Heart failure,strict

502

2060

1.71

26.53

1.3

—

nmol/l

—

Personality disorders, excluding more controls

251

1204

2.10

26.43

1.2

1.3

—

nmol/l

—

Dermatitis

619

3834

1.59

25.80

1.3

—

nmol/l

—

Abnormal involuntary movements

161

653

2.50

25.57

1.3

—

nmol/l

—

Bacterial Sepsis

448

2152

1.73

25.51

1.4

1.3

—

nmol/l

—

Epilepsy

274

1377

2.00

25.33

1.4

1.3

—

nmol/l

—

Disorders of synovium and tendon

505

2599

1.66

24.57

1.2

1.4

—

nmol/l

—

Nonorganic sleeping disorders, excluding more controls

210

974

2.18

24.36

1.3

—

nmol/l

—

Substance abuse, excluding more controls

498

2522

1.66

24.28

1.3

—

nmol/l

—

Other symptoms and signs involving the circulatory and respiratory systems

217

3.66

24.18

1.3

1.4

—

nmol/l

—

Gonarthrosis

589

2070

1.62

24.05

1.3

—

nmol/l

—

Myocardial infarction, without ST-elevation

360

1832

1.79

23.17

1.4

1.3

—

nmol/l

—

COPD (mode)

291

1188

1.93

23.13

1.3

—

nmol/l

—

Other disorders of kidney and ureter

154

642

2.44

23.11

1.5

1.4

—

nmol/l

—

Other enthesopathies

298

1599

1.88

22.97

1.2

1.3

—

nmol/l

—

Cervicobrachial syndrome

227

1111

2.06

22.92

1.3

—

nmol/l

—

Disorder of lipoprotein metabolism, unspecified

135

531

2.58

22.90

1.5

1.3

—

nmol/l

—

GI-bleeding

296

1589

1.88

22.78

1.4

1.3

—

nmol/l

—

Other and unspecified dermatitis

520

3277

1.60

22.35

1.3

—

nmol/l

—

Postviral fatigue syndrome

8.70

22.08

1.6

1.3

—

nmol/l

—

Hyperkalaemia

193

3.70

22.05

1.2

1.3

—

nmol/l

—

Caries of dentine

229

1097

2.03

22.05

1.3

—

nmol/l

—

Other diseases of the digestive system

296

1608

1.86

21.97

1.4

1.3

—

nmol/l

—

Myocardial infarction, strict

400

1654

1.72

21.83

1.4

1.3

—

nmol/l

—

Non-selective monoamine reuptake inhibitors

358

1976

1.75

21.78

1.3

—

nmol/l

—

Dental caries

250

1214

1.96

21.69

1.4

1.3

—

nmol/l

—

Migraine with aura and triptan purchases

174

790

2.23

21.40

1.2

1.3

—

nmol/l

—

Heart failure, strict

536

2358

1.59

21.33

1.3

—

nmol/l

—

Benign neoplasm: Colon

519

3098

1.58

21.26

1.4

1.3

—

nmol/l

—

Carpal tunnel syndrome

588

3328

1.54

21.13

1.2

1.3

—

nmol/l

—

Drug-induced adrenocortical insufficiency

5.59

21.13

1.8

1.3

—

nmol/l

—

Presence of other functional implants

550

2408

1.57

20.90

1.3

—

nmol/l

—

Glomerular disorders in diseases classified elsewhere

132

540

2.48

20.70

1.2

1.3

—

nmol/l

—

Migraine without aura and triptan purchases

177

821

2.18

20.65

1.2

1.3

—

nmol/l

—

Acute renal failure

213

1060

2.03

20.62

1.2

1.3

—

nmol/l

—

Enlarged lymph nodes

150

652

2.32

20.46

1.3

—

nmol/l

—

Extracorporeal dialysis

248

3.26

20.43

1.5

1.3

—

nmol/l

—

Ovarian cyst

331

1056

1.81

20.29

1.3

—

nmol/l

—

Enthesopathies of lower limb, excluding foot

227

1165

1.97

20.13

1.2

1.3

—

nmol/l

—

All-cause Heart Failure

523

2323

1.57

20.09

1.3

—

nmol/l

—

Care involving dialysis

346

2.86

20.05

1.5

1.4

—

nmol/l

—

Intestinal malabsorption

217

3.41

19.92

1.4

1.2

—

nmol/l

—

Gonarthrosis,primary

805

3387

1.44

19.61

1.3

—

nmol/l

—

Intestinal stricture

297

1685

1.78

19.20

1.4

1.3

—

nmol/l

—

Conduction disorders

253

1090

1.87

18.74

1.3

—

nmol/l

—

Corticotropin deficiency

8.38

18.54

1.2

1.3

—

nmol/l

—

Other or unspecified ileus, impaction or obstruction

169

804

2.12

18.50

1.4

1.3

—

nmol/l

—

Transient ischemic attack

472

2411

1.57

18.29

1.3

—

nmol/l

—

Benign neoplasm: Pancreas

125

4.15

18.25

1.6

1.3

—

nmol/l

—

Other and unspecified urticaria

207

1067

1.96

18.21

1.2

1.3

—

nmol/l

—

Cardiac arrest

114

3.99

17.93

1.7

1.3

—

nmol/l

—

Other diseases of pancreas

105

414

2.58

17.90

1.3

—

nmol/l

—

Unstable angina pectoris

307

1394

1.74

17.87

1.4

1.3

—

nmol/l

—

COPD

391

1961

1.63

17.84

1.4

1.3

—

nmol/l

—

Dialysis, with operation codes

131

572

2.32

17.81

1.4

1.3

—

nmol/l

—

Chronic gastritis

243

1329

1.84

17.79

1.4

1.3

—

nmol/l

—

Cervicocranial syndrome

114

468

2.47

17.79

1.2

1.3

—

nmol/l

—

Early onset COPD, excluding more controls

180

891

2.04

17.70

1.2

1.3

—

nmol/l

—

Elevated blood glucose level

382

2.63

17.63

1.3

—

nmol/l

—

Heartburn

115

479

2.43

17.39

1.2

1.4

—

nmol/l

—

Other congenital malformations

373

2.64

17.36

2.3

1.3

—

nmol/l

—

148

687

2.18

17.34

1.5

1.3

—

nmol/l

—

AV-block

156

625

2.15

17.24

1.3

—

nmol/l

—

Other chronic obstructive pulmonary disease

372

1883

1.63

16.92

1.3

—

nmol/l

—

Pain associated with micturition

130

581

2.27

16.76

1.3

—

nmol/l

—

Arthrosis

607

2264

1.47

16.62

1.3

—

nmol/l

—

Osteoporosis

273

1445

1.75

16.61

1.4

1.3

—

nmol/l

—

Other chronic obstructive pulmonary disease, including avohilmo

472

2544

1.53

16.61

1.3

—

nmol/l

—

Soft tissue disorders related to use, overuse and pressure

260

1483

1.77

16.59

1.2

1.3

—

nmol/l

—

Nephropathy related operations

128

574

2.26

16.39

1.4

1.3

—

nmol/l

—

Adjustment and management of implanted device

164

811

2.04

16.28

1.3

—

nmol/l

—

Factors influencing health status and contact with health services

210

542

1.95

16.01

1.4

1.2

—

nmol/l

—

Mental and behavioural disorders due to tobacco

104

432

2.45

15.92

1.3

—

nmol/l

—

Smoking dependency

104

432

2.45

15.92

1.3

—

nmol/l

—

ILD medications: immunosuppressive drugs

566

3532

1.46

15.90

1.3

—

nmol/l

—

Stroke, excluding SAH

522

2539

1.49

15.88

1.4

1.3

—

nmol/l

—

Panic disorder

145

692

2.12

15.86

1.4

1.3

—

nmol/l

—

Radiculopathy

147

709

2.09

15.64

1.4

1.3

—

nmol/l

—

Cluster headache, wide

150

3.54

15.45

1.4

1.5

—

nmol/l

—

Obesity, other/unspecified

315

1934

1.64

15.32

1.2

1.3

—

nmol/l

—

Algoneurodystrophy

152

3.52

15.19

1.2

1.4

—

nmol/l

—

Restless leg syndrome

153

759

2.04

15.14

1.3

—

nmol/l

—

Myocarditis

106

4.02

15.04

1.4

1.3

—

nmol/l

—

Gastroduodenal ulcer

212

1173

1.81

14.88

1.4

1.3

—

nmol/l

—

Cardiodefibrillation

302

1850

1.64

14.67

1.3

1.4

—

nmol/l

—

COPD related to multimorbidity

331

1748

1.61

14.61

1.4

1.3

—

nmol/l

—

Other disorders of bladder

119

544

2.21

14.59

1.3

1.4

—

nmol/l

—

Asthma-related pneumonia

320

1992

1.61

14.51

1.4

1.3

—

nmol/l

—

Cerebral cysts

240

2.88

14.46

1.4

1.3

—

nmol/l

—

Asthma, hospital admissions 3, pneumonia

320

1996

1.61

14.40

1.4

1.3

—

nmol/l

—

Asthma-related pneumonia or sepsis

320

1996

1.61

14.40

1.4

1.3

—

nmol/l

—

Stroke, including SAH

542

2695

1.45

14.35

1.4

1.3

—

nmol/l

—

Unknown and unspecified causes of morbidity

263

2.78

14.33

1.3

1.4

—

nmol/l

—

Benign neoplasm of brain and other parts of central nervous system

287

2.70

14.24

2.1

1.3

—

nmol/l

—

Phobic anxiety disorders

127

600

2.13

14.21

1.2

1.3

—

nmol/l

—

Any operation in hilmo

8.37

14.16

1.5

1.0

—

nmol/l

—

Later onset COPD, excluding more controls

183

741

1.90

14.13

1.5

1.3

—

nmol/l

—

Disorders of adrenal gland, other and/or unspecified

15.12

14.13

1.6

1.2

—

nmol/l

—

Other symptoms and signs involving the urinary system

102

445

2.32

14.01

1.3

1.4

—

nmol/l

—

Undetermined asthma, excluding more controls

125

593

2.13

13.92

1.3

1.2

—

nmol/l

—

Unspecified haematuria

348

1812

1.57

13.87

1.4

1.3

—

nmol/l

—

Meniscus derangement

462

2069

1.49

13.83

1.3

—

nmol/l

—

Other symptoms and signs involving cognitive functions and awareness

394

2304

1.52

13.81

1.3

—

nmol/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

326

1614

1.59

13.75

1.3

—

nmol/l

—

Volume depletion

333

2.52

13.70

1.7

1.3

—

nmol/l

—

Other and unspecified polyneuropathies, also in other diseases

175

941

1.88

13.70

1.4

1.3

—

nmol/l

—

Polyarthrosis

202

1017

1.80

13.68

1.3

—

nmol/l

—

Panhypopituitarism

4.80

13.65

1.8

1.3

—

nmol/l

—

Undetermined asthma

125

599

2.11

13.57

1.3

—

nmol/l

—

Special screening examination for other diseases and disorders

107

485

2.22

13.37

1.2

—

nmol/l

—

Ventral hernia

221

1284

1.73

13.35

1.5

1.3

—

nmol/l

—

Cluster headache, strict

140

3.43

13.34

1.4

1.5

—

nmol/l

—

Unspecified/other endometriosis

391

2.36

13.22

1.2

1.3

—

nmol/l

—

Type 1 diabetes

205

1167

1.77

13.21

1.4

1.3

—

nmol/l

—

Neuralgia and neuritis, unspecified

236

2.81

13.16

1.2

1.3

—

nmol/l

—

Neuromuscular dysfunction of bladder

427

2.30

13.09

1.3

1.4

—

nmol/l

—

Other specified/unspecified arthritis

238

1420

1.69

13.03

1.3

—

nmol/l

—

Hypogonadotropic hypogonadism

123

3.58

13.01

1.5

—

nmol/l

—

Deforming dorsopathies

241

1444

1.68

12.96

1.3

—

nmol/l

—

Pain and other conditions associated with female genital organs and menstrual cycle

190

883

1.81

12.96

1.1

1.3

—

nmol/l

—

Transport accidents

410

2297

1.49

12.95

1.2

1.4

—

nmol/l

—

Cerebral aneurysm, nonruptured

442

2.27

12.95

1.7

1.3

—

nmol/l

—

Other disorders of glucose regulation and pancreatic internal secretion

361

2.41

12.93

1.4

1.3

—

nmol/l

—

Excessive, frequent and irregular menstruation

323

1083

1.60

12.86

1.3

—

nmol/l

—

Hypercalcemia

201

2.95

12.83

1.3

—

nmol/l

—

Primary gonarthrosis, bilateral

453

2610

1.46

12.83

1.2

1.3

—

nmol/l

—

Malignant neoplasm of thyroid gland, including Hilmo

388

2.36

12.79

1.9

1.3

—

nmol/l

—

Nontoxic multinodular goitre

192

1086

1.78

12.79

1.3

—

nmol/l

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

179

2.76

12.78

1.5

1.3

—

nmol/l

—

Cardiomyopathy

143

736

1.96

12.77

1.3

—

nmol/l

—

COPD-related respiratory insufficiency

106

489

2.19

12.77

1.4

1.3

—

nmol/l

—

Other enthesopathy of foot (+metatarsalgia)

110

516

2.16

12.71

1.2

1.3

—

nmol/l

—

Malignant neoplasm of thyroid gland

353

2.42

12.65

1.9

1.3

—

nmol/l

—

Other diseases of liver

179

995

1.82

12.64

1.3

—

nmol/l

—

Brachial plexus disorders

434

2.26

12.61

1.3

1.4

—

nmol/l

—

Other sleep disorders

100

453

2.23

12.59

1.3

—

nmol/l

—

COPD, early/later onset

372

2075

1.51

12.56

1.3

—

nmol/l

—

Mixed hyperlipidaemia

136

3.37

12.50

1.2

1.4

—

nmol/l

—

Hypoglycaemia, other or unspecified

289

2.56

12.47

1.3

—

nmol/l

—

Benign neoplasm: Kidney

162

3.16

12.45

1.3

—

nmol/l

—

Aortic aneurysm

175

951

1.82

12.40

1.3

—

nmol/l

—

COPD, hospital admissions

368

2063

1.51

12.36

1.3

—

nmol/l

—

Internal derangement of knee

312

1998

1.55

12.25

1.3

—

nmol/l

—

Adenomyosis (Endometriosis of uterus)

136

699

1.96

12.21

1.3

—

nmol/l

—

Unspecified kidney failure

396

2.30

12.17

1.3

1.4

—

nmol/l

—

Implicit fungal Sepsis, including avohilmo

335

2.42

12.14

1.4

1.3

—

nmol/l

—

Polyneuropathies and other disorders of the peripheral nervous system

191

1097

1.76

12.08

1.4

1.3

—

nmol/l

—

Cluster headache, wide,, including avohilmo

248

2.67

12.00

1.4

—

nmol/l

—

Other diseases of stomach and duodenum

283

2.55

11.98

1.2

—

nmol/l

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

444

2.21

11.97

1.2

1.3

—

nmol/l

—

Other arthrosis

435

2005

1.46

11.94

1.3

—

nmol/l

—

Other diseases of intestine

139

727

1.93

11.91

1.4

1.3

—

nmol/l

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

346

2.37

11.77

1.5

1.3

—

nmol/l

—

Post-traumatic stress disorder

346

2.37

11.74

1.4

1.3

—

nmol/l

—

Dissociative [conversion] disorders

152

3.15

11.72

1.6

1.3

—

nmol/l

—

Haemorrhage, not elsewhere classified

117

3.48

11.69

1.3

—

nmol/l

—

Ocular pain

410

2.25

11.68

1.4

1.3

—

nmol/l

—

Peripheral artery disease

338

1768

1.52

11.55

1.3

—

nmol/l

—

Faecal incontinence

406

2.24

11.51

1.2

1.4

—

nmol/l

—

Gout

215

1103

1.68

11.47

1.3

1.4

—

nmol/l

—

Cardiac murmurs and other cardiac sounds

333

2.37

11.47

1.7

1.3

—

nmol/l

—

Other and unspecified drugs and medicaments

414

2.23

11.42

1.3

—

nmol/l

—

Metatarsalgia

101

480

2.13

11.35

1.2

1.4

—

nmol/l

—

Nonalcoholic fatty liver disease

109

536

2.06

11.21

1.2

1.4

—

nmol/l

—

Oxicams

166

514

1.84

11.18

1.3

—

nmol/l

—

Benign neoplasm: Rectum, anus and anal canal

183

1063

1.74

11.17

1.5

1.3

—

nmol/l

—

Combinations of oral blood glucose lowering drugs

229

1411

1.63

11.15

1.3

—

nmol/l

—

Thoracic aortic aneurysm

122

627

1.96

11.06

1.3

—

nmol/l

—

Cluster headache, strict, including avohilmo

230

2.65

11.01

1.4

—

nmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

217

1306

1.65

11.00

1.4

1.3

—

nmol/l

—

Intestinal adhesions without obstruction

363

2.29

10.99

1.5

1.4

—

nmol/l

—

Sicca syndrome [Sjögren]

454

2.15

10.97

1.3

—

nmol/l

—

Ischaemic Stroke, excluding all haemorrhages

462

2413

1.41

10.94

1.4

1.3

—

nmol/l

—

Other specified/unspecified soft tissue disorders

208

2.74

10.93

1.3

—

nmol/l

—

Persons encountering health services for specific procedures, not carried out

409

2.20

10.91

1.4

1.3

—

nmol/l

—

Other inflammation of eyelid

139

750

1.87

10.89

1.4

1.3

—

nmol/l

—

Benign neoplasm: Parathyroid gland

4.94

10.85

1.4

1.3

—

nmol/l

—

Benign neoplasm: Spinal cord

4.88

10.81

3.0

1.3

—

nmol/l

—

Hypoparathyroidism

150

3.07

10.71

1.4

1.2

—

nmol/l

—

Disorders resulting from impaired renal tubular function

150

3.07

10.71

1.2

1.4

—

nmol/l

—

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

9.11

10.69

3.3

1.4

—

nmol/l

—

Hyperosmolality and hypernatraemia

5.42

10.66

1.3

1.2

—

nmol/l

—

Other shoulder lesions

459

2.11

10.65

1.2

1.3

—

nmol/l

—

Type 1 diabetes, wide definition, subgroup 1

168

967

1.75

10.56

1.3

—

nmol/l

—

Benign neoplasm of urinary organs

212

2.69

10.55

1.4

1.2

—

nmol/l

—

Diseases of oral cavity, salivary glands and jaws

454

1647

1.42

10.53

1.4

1.3

—

nmol/l

—

Other disorders of white blood cells

230

2.61

10.48

1.3

1.2

—

nmol/l

—

Malignant neoplasm of other endocrine glands and related structures

20.90

10.44

3.3

1.9

—

nmol/l

—

Other diseases of pleura

356

2124

1.46

10.38

1.4

1.3

—

nmol/l

—

Primary adrenocortical insufficiency

5.10

10.37

3.0

1.3

—

nmol/l

—

Menorrhagia

280

1003

1.56

10.36

1.3

—

nmol/l

—

Coxarthrosis

402

1808

1.44

10.32

1.3

—

nmol/l

—

COPD, hospital admission 2, with asthma infections

248

1360

1.58

10.31

1.4

1.3

—

nmol/l

—

Presence of cardiac and vascular implants and grafts

344

1724

1.47

10.17

1.3

1.4

—

nmol/l

—

Other and unspecified disorders of vitreous body

383

2629

1.43

10.12

1.2

1.3

—

nmol/l

—

Peripheral arterial reconstruction

132

718

1.85

10.10

1.3

—

nmol/l

—

Spondylolisthesis/Spondylolysis

159

915

1.75

10.08

1.3

—

nmol/l

—

Collagenous colitis

476

2.06

10.08

1.3

—

nmol/l

—

Non-ischemic cardiomyopathy

250

1269

1.57

10.07

1.3

—

nmol/l

—

Other diseases of hard tissues of teeth

448

1645

1.42

10.04

1.4

1.3

—

nmol/l

—

Benign neoplasm: Endocrine pancreas

8.00

9.97

1.5

1.2

—

nmol/l

—

Abnormal results of function studies

438

2.10

9.96

1.7

1.3

—

nmol/l

—

Vascular disorders of the intestines

248

2.49

9.92

1.3

—

nmol/l

—

Atypical facial pain

256

2.46

9.81

1.4

1.3

—

nmol/l

—

Autonomic disorders

3.52

9.81

1.5

1.3

—

nmol/l

—

Other postsurgical states

293

2.35

9.76

1.8

1.3

—

nmol/l

—

Diplopia

121

648

1.89

9.76

1.4

1.3

—

nmol/l

—

Otalgia

389

2.16

9.73

1.4

1.3

—

nmol/l

—

Trochanteric bursitis

140

786

1.80

9.70

1.2

1.3

—

nmol/l

—

Type 1 diabetes, wide definition

171

1014

1.69

9.69

1.3

1.2

—

nmol/l

—

Familial hypercholesterolemia

115

607

1.91

9.68

1.4

1.3

—

nmol/l

—

Retention of urine

253

1326

1.55

9.68

1.3

—

nmol/l

—

Hypocalcemia

3.49

9.67

1.2

1.3

—

nmol/l

—

Malignant neoplasm of small intestine, including Hilmo

138

3.04

9.64

1.6

1.3

—

nmol/l

—

Dental operations

484

1802

1.39

9.62

1.4

1.3

—

nmol/l

—

Aneurysms, operations, SAH

146

836

1.76

9.46

1.6

1.3

—

nmol/l

—

Diseases of male genital organs

346

1190

1.47

9.44

1.3

1.4

—

nmol/l

—

Gastric ulcer

137

772

1.79

9.37

1.3

—

nmol/l

—

Abnormalities of gait and mobility

108

567

1.92

9.28

1.3

—

nmol/l

—

Paracetamol or NSAID medication

103

254

2.05

9.25

1.3

1.1

—

nmol/l

—

Pruritus

114

610

1.89

9.25

1.3

—

nmol/l

—

Other complications of surgical and medical care, not elsewhere classified

479

2.00

9.19

1.2

1.3

—

nmol/l

—

Heart failure and bmi 25plus

308

1396

1.48

9.16

1.3

—

nmol/l

—

Family history of other specific disorders

4.70

9.13

2.9

1.2

—

nmol/l

—

Early lumbar disc prolapse, operated

406

2.09

9.11

1.3

—

nmol/l

—

Other diseases of the respiratory system

162

965

1.69

9.11

1.5

1.3

—

nmol/l

—

Other respiratory disorders and diseases

162

965

1.69

9.11

1.5

1.3

—

nmol/l

—

Cyst of kidney

322

2.23

9.08

1.3

—

nmol/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

201

1078

1.61

9.07

1.4

1.3

—

nmol/l

—

Crohn's disease NAS

278

2.33

9.06

1.3

1.4

—

nmol/l

—

Diseases of pulp and periapical tissues and dental caries

518

1966

1.36

9.01

1.3

—

nmol/l

—

Anankastic personality disorder

160

2.80

9.01

1.3

1.5

—

nmol/l

—

Other noninflammatory disorders of uterus, except cervix

192

787

1.64

8.97

1.4

1.3

—

nmol/l

—

Vitamin deficiency

201

2.58

8.92

1.4

1.3

—

nmol/l

—

Vitamin deficiency, wide

201

2.58

8.92

1.4

1.3

—

nmol/l

—

Thyrotropin deficiency

5.05

8.92

1.2

1.3

—

nmol/l

—

Benign neoplasm: Rectum

159

950

1.69

8.87

1.5

1.3

—

nmol/l

—

Hyperfunction of pituitary gland

184

2.65

8.87

1.7

1.2

—

nmol/l

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

113

3.16

8.85

1.1

1.3

—

nmol/l

—

Coxarthrosis [arthrosis of hip](FG)

437

2194

1.37

8.80

1.3

—

nmol/l

—

Dialysis

146

2.86

8.73

1.2

1.3

—

nmol/l

—

Osteoporosis with pathological fracture (FG)

374

2.11

8.69

1.2

1.3

—

nmol/l

—

Disorders of lens

542

2533

1.33

8.69

1.3

—

nmol/l

—

Cardiomyopathy, other and unspecified

322

2.20

8.65

1.3

1.4

—

nmol/l

—

Duodenal ulcer

408

2.05

8.62

1.5

1.3

—

nmol/l

—

Benign neoplasm: Caecum

102

545

1.89

8.37

1.3

—

nmol/l

—

Immunodeficiencies

226

2.43

8.36

1.2

1.3

—

nmol/l

—

Sensorineural hearing loss

609

3132

1.30

8.36

1.3

—

nmol/l

—

Gonarthrosis, primary, with knee surgery

470

2733

1.34

8.32

1.2

1.3

—

nmol/l

—

Senile cataract

502

2290

1.34

8.29

1.3

—

nmol/l

—

Other/unspecified enthesopathies of lower limb, excluding foot

296

2.22

8.25

1.2

1.3

—

nmol/l

—

Problems related to lifestyle

472

1.94

8.16

1.4

1.3

—

nmol/l

—

Immunodeficiency with predominantly antibody defects

119

3.01

8.14

1.2

1.4

—

nmol/l

—

Early onset COPD

180

1135

1.60

8.14

1.2

1.3

—

nmol/l

—

Other disorders involving the immune mechanism, not elsewhere classified

119

3.00

8.12

1.1

1.4

—

nmol/l

—

Neurofibromatosis, type 1

7.66

8.12

2.6

1.4

—

nmol/l

—

Status epilepticus

119

2.99

8.11

1.7

1.4

—

nmol/l

—

Glomerulonephritis

446

1.97

8.09

1.2

1.3

—

nmol/l

—

Iron deficiency anaemia secondary to blood loss (chronic)

134

786

1.72

8.05

1.4

1.3

—

nmol/l

—

Social phobias

348

2.09

7.86

1.1

1.3

—

nmol/l

—

Pulmonary heart disease, diseases of pulmonary circulation

255

1746

1.47

7.85

1.4

1.3

—

nmol/l

—

Oesophagitis

202

2.46

7.84

1.4

1.3

—

nmol/l

—

Sacroiliitis, not elsewhere classified

161

2.64

7.79

1.3

—

nmol/l

—

Other abnormal uterine and vaginal bleeding

187

854

1.58

7.76

1.2

1.3

—

nmol/l

—

Gout, strict definition

138

825

1.68

7.74

1.3

—

nmol/l

—

Benign neoplasm: Sigmoid colon

163

1017

1.61

7.74

1.5

1.3

—

nmol/l

—

Psychotic depression

247

2.29

7.70

1.5

1.4

—

nmol/l

—

Viral hepatitis, IBD co-morbidity

112

2.97

7.65

1.4

1.2

—

nmol/l

—

Malignant neoplasm of small intestine

102

3.11

7.65

1.6

1.3

—

nmol/l

—

Gout, FINNGEN

215

1422

1.51

7.62

1.3

1.4

—

nmol/l

—

Other and unspecified abdominal hernia

175

2.56

7.62

1.2

1.3

—

nmol/l

—

Dental caries, including avohilmo

575

2270

1.30

7.61

1.3

—

nmol/l

—

Conductive and sensorineural hearing loss

634

3308

1.28

7.57

1.3

—

nmol/l

—

Diseases of the myoneural junction and muscle

106

595

1.80

7.47

1.5

1.3

—

nmol/l

—

N06DA Anticholinesterases

109

1442

0.58

7.40

1.4

1.3

—

nmol/l

—

Use of anticholinesterases

109

1442

0.58

7.40

1.4

1.3

—

nmol/l

—

Benign neoplasm: Transverse colon

532

1.84

7.39

1.5

1.3

—

nmol/l

—

Other and unspecified visual disturbances

533

1.84

7.34

1.2

1.3

—

nmol/l

—

Scleritis and episcleritis

298

2.14

7.34

1.6

1.4

—

nmol/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

186

1212

1.54

7.34

1.3

—

nmol/l

—

Intracerebral haemorrhage

526

1.84

7.31

1.6

1.3

—

nmol/l

—

Gingival hyperplasia

150

2.64

7.24

1.7

1.4

—

nmol/l

—

Budesonide

123

728

1.70

7.20

1.3

—

nmol/l

—

Peroneal tendinitis

4.00

7.20

1.2

1.3

—

nmol/l

—

324

2116

1.38

7.13

1.4

1.3

—

nmol/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

275

2.16

7.10

1.2

1.3

—

nmol/l

—

Lateral epicondylitis

116

679

1.72

7.09

1.2

1.3

—

nmol/l

—

Gout, idiopatic and unspecified

182

1190

1.54

7.08

1.3

—

nmol/l

—

Degeneration of macula and posterior pole

383

2199

1.35

7.06

1.3

—

nmol/l

—

Vitamin D deficiency

3.29

7.03

1.4

1.2

—

nmol/l

—

Pure hyperglyceridaemia

3.27

7.01

1.3

1.5

—

nmol/l

—

Spontaneous rupture of synovium and tendon

392

1.96

7.00

1.3

—

nmol/l

—

Pulmonary heart disease

232

1599

1.46

6.97

1.4

1.3

—

nmol/l

—

Pulmonary embolism

232

1599

1.46

6.97

1.4

1.3

—

nmol/l

—

Implicit fungal Sepsis

153

2.59

6.96

1.5

1.3

—

nmol/l

—

Unspecific neurodegenerative disorder

156

1658

0.64

6.92

1.3

—

nmol/l

—

Acute gastritis

299

2.09

6.88

1.2

1.3

—

nmol/l

—

Nephrotic syndrome

114

2.86

6.88

1.1

1.3

—

nmol/l

—

Disorders of continuity of bone

501

1.83

6.88

1.2

1.3

—

nmol/l

—

Fungal Sepsis

166

2.50

6.87

1.4

1.3

—

nmol/l

—

Arthropathies in other diseases classified elsewhere

149

2.59

6.81

1.2

1.4

—

nmol/l

—

Skin changes due to chronic exposure to nonionizing radiation

304

1994

1.39

6.80

1.3

—

nmol/l

—

Postmenopausal osteoporosis with pathological fracture

369

1.98

6.80

1.2

1.3

—

nmol/l

—

221

1298

1.47

6.79

1.3

—

nmol/l

—

Cerebral palsy and other paralytic syndromes

532

1.80

6.79

1.3

—

nmol/l

—

Pituitary-dependent Cushing's disease

10.99

6.71

1.4

1.8

—

nmol/l

—

Cystic kidney disease

127

2.72

6.70

1.6

1.3

—

nmol/l

—

Other specified/unspecified bacterial intestinal infections

316

2.05

6.70

1.5

1.3

—

nmol/l

—

Bipolar affective disorders

149

944

1.59

6.69

1.2

1.3

—

nmol/l

—

Fracture of rib(s), sternum and thoracic spine

237

1654

1.44

6.69

1.3

—

nmol/l

—

Diabetic maculopathy, excluding more controls

455

1.86

6.69

1.2

1.3

—

nmol/l

—

Benign neoplasm: Brain, supratentorial

3.80

6.69

1.8

1.4

—

nmol/l

—

Respiratory insufficiency

302

2.06

6.65

1.6

1.3

—

nmol/l

—

Propionic acid derivatives

180

583

1.56

6.63

1.3

—

nmol/l

—

Other and unspecified disorders of white blood cells

169

2.46

6.63

1.2

—

nmol/l

—

Later onset COPD

192

1028

1.51

6.62

1.4

1.3

—

nmol/l

—

Polyglandular dysfunction

15.84

6.57

2.3

1.1

—

nmol/l

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

190

1236

1.50

6.54

1.9

1.3

—

nmol/l

—

Benign neoplasm: Endocrine gland, other/unspecified

8.94

6.52

1.8

1.3

—

nmol/l

—

Calcific aortic valvular stenosis, operated

204

1337

1.47

6.52

1.3

—

nmol/l

—

Calcific aortic valvular stenosis

204

1337

1.47

6.52

1.3

—

nmol/l

—

Other or ill-defined heart diseases

189

2.35

6.48

1.8

1.3

—

nmol/l

—

Other diseases of oesophagus

396

1.91

6.47

1.4

1.3

—

nmol/l

—

Small fibre neuropathy

124

2.71

6.45

1.3

—

nmol/l

—

Trigeminal neuralgia

274

2.10

6.42

1.3

—

nmol/l

—

Inflammatory diseases of prostate (prostatitis)

476

1.82

6.40

1.3

—

nmol/l

—

Laparoscopic right hemicolectomy

268

2.12

6.39

1.3

—

nmol/l

—

Sequelae of cerebrovascular disease

264

1612

1.40

6.38

1.4

1.3

—

nmol/l

—

Actinic keratosis

292

1934

1.38

6.38

1.3

—

nmol/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

203

1336

1.47

6.36

1.3

—

nmol/l

—

Operations 2 for CAVS

203

1336

1.47

6.36

1.3

—

nmol/l

—

Neuroendocrine tumor and carcinoma of small intestine

3.43

6.34

1.2

—

nmol/l

—

Wide developmental disorders, excluding more controls

3.00

6.34

1.1

1.4

—

nmol/l

—

Gout, unspecified

149

957

1.57

6.34

1.3

—

nmol/l

—

Barrett oesophagus

204

2.28

6.33

1.4

1.3

—

nmol/l

—

Benign neoplasm: Colon, unspecified

201

1376

1.47

6.32

1.3

—

nmol/l

—

Other specified/unspecified inflammatory spondylopathies

173

2.40

6.30

1.4

—

nmol/l

—

Use of pramipexole

181

1219

1.49

6.20

1.2

1.3

—

nmol/l

—

Congenital malformations of the urinary system, including avohilmo

258

2.12

6.19

1.5

1.3

—

nmol/l

—

Other aneurysm

187

2.32

6.18

1.4

1.3

—

nmol/l

—

Other blood glucose lowering drugs, excl. Insulins

119

729

1.64

6.18

1.3

—

nmol/l

—

Hyperprolactinaemia

121

2.68

6.18

1.3

1.2

—

nmol/l

—

Calcific aortic valvular stenosis, including rheumatic fever

203

1343

1.46

6.17

1.3

—

nmol/l

—

Lesion of ulnar nerve

114

692

1.66

6.14

1.3

—

nmol/l

—

Eosinophilic disease (BM)

3.83

6.13

1.4

—

nmol/l

—

162

995

1.53

6.12

1.3

—

nmol/l

—

Neuroendocrine tumor and carcinoma of pancreas

5.83

6.11

2.4

1.4

—

nmol/l

—

Familial hypercholesterolemia, with ischemic heart disease

348

1.94

6.10

1.3

—

nmol/l

—

Dermatographic urticaria

321

1.98

6.08

1.3

—

nmol/l

—

Extreme obesity with alveolar hypoventilation

189

2.31

6.07

1.2

1.3

—

nmol/l

—

Other and unspecified mononeuropathies of lower limb

111

2.75

6.05

1.1

1.3

—

nmol/l

—

Injuries to unspecified part of trunk, limb or body region

478

1.79

6.04

1.5

1.3

—

nmol/l

—

Other disorders of conjunctiva

116

711

1.64

6.03

1.2

1.3

—

nmol/l

—

Ménière disease

465

1.80

5.99

1.4

1.3

—

nmol/l

—

COPD, hospital admissions 1, only main diagnosis

243

1492

1.40

5.94

1.3

—

nmol/l

—

Malignant neoplasm of digestive organs, including Hilmo

327

1795

1.34

5.93

1.4

1.3

—

nmol/l

—

Kidney transplant status

210

2.22

5.93

1.5

1.4

—

nmol/l

—

Other and/or unspecified nontoxic goitre

416

1.85

5.92

1.4

1.3

—

nmol/l

—

Other peripheral vertigo

467

1.79

5.91

1.2

1.3

—

nmol/l

—

Congenital malformations of the urinary system

250

2.10

5.89

1.5

1.3

—

nmol/l

—

Crohn's disease of small intestine

311

1.98

5.88

1.3

1.4

—

nmol/l

—

Emphysema

270

2.05

5.88

1.5

1.3

—

nmol/l

—

Other dialysis

113

2.70

5.86

1.2

1.4

—

nmol/l

—

Dystonia

271

2.05

5.85

1.6

1.3

—

nmol/l

—

Bruxism

3.13

5.81

1.3

—

nmol/l

—

Cramp and spasm

212

2.20

5.81

1.3

1.4

—

nmol/l

—

Diseases of peritoneum

485

1.77

5.78

1.3

—

nmol/l

—

Isolated proteinuria with specified morphological lesion

4.01

5.76

1.8

1.4

—

nmol/l

—

Abnormal serum enzyme levels

209

1417

1.43

5.72

1.3

1.4

—

nmol/l

—

Rheumatoid arthritis

238

1513

1.40

5.70

1.2

1.3

—

nmol/l

—

KRA_PSY_EATING, excluding more controls

264

2.04

5.68

1.4

1.3

—

nmol/l

—

Other disorders of the musculoskeletal system and connective tissue

125

793

1.59

5.67

1.2

1.3

—

nmol/l

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

488

1.76

5.66

1.4

1.3

—

nmol/l

—

Special screening examination for infectious and parasitic diseases

149

709

1.54

5.66

1.3

—

nmol/l

—

Other diseases of pericardium

176

2.30

5.64

1.6

1.4

—

nmol/l

—

Other and unspecified injuries of lower leg

351

1.90

5.64

1.2

1.4

—

nmol/l

—

Diseases of tongue

261

2.05

5.63

1.2

1.3

—

nmol/l

—

Gluteal tendinitis

202

2.21

5.62

1.2

1.4

—

nmol/l

—

Other disorders of binocular movement

2.98

5.60

1.4

1.2

—

nmol/l

—

Other disorders of nervous system

317

1.94

5.60

1.3

—

nmol/l

—

Disorders of muscles

475

1.76

5.59

1.2

1.3

—

nmol/l

—

Viral meningitis, including avohilmo

159

2.36

5.52

1.3

1.4

—

nmol/l

—

Ganglion

161

1086

1.49

5.51

1.3

—

nmol/l

—

Ehlers-Danlos syndrome, including avohilmo

3.55

5.50

1.2

—

nmol/l

—

Fentanyl

396

1.83

5.50

1.4

1.3

—

nmol/l

—

Benign neoplasm: Stomach

508

1.73

5.48

1.5

1.3

—

nmol/l

—

Colectomy operation

133

863

1.55

5.48

1.4

1.3

—

nmol/l

—

Selective deficiency of immunoglobulin G [IgG] subclasses

5.42

5.48

1.1

1.4

—

nmol/l

—

Delirium, not induced by alcohol and other psychoactive substances

552

1.69

5.45

1.5

1.3

—

nmol/l

—

Diabetes insipidus

5.35

5.45

1.8

1.2

—

nmol/l

—

Radial styloid tenosynovitis [de Quervain]

265

2.02

5.43

1.4

—

nmol/l

—

Anti-inflammatory and antirheumatic products, non-steroids

173

583

1.50

5.42

1.3

—

nmol/l

—

Hydronephrosis

502

1.72

5.42

1.4

—

nmol/l

—

Cystic kidney disease, including avohilmo

142

2.43

5.41

1.6

1.3

—

nmol/l

—

Achilles tendinitis

480

1.74

5.41

1.2

1.3

—

nmol/l

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

3.07

5.41

1.2

1.3

—

nmol/l

—

Malignant neoplasm of pancreas, including Hilmo

378

1.84

5.39

1.6

1.3

—

nmol/l

—

Nonhereditary hypogammaglobulinemia

3.65

5.38

1.1

1.3

—

nmol/l

—

Aortic valve malfunction, age under 60 years

459

1.76

5.37

1.5

1.3

—

nmol/l

—

Impotence

206

2.16

5.36

1.4

—

nmol/l

—

Acute pancreatitis

145

965

1.51

5.32

1.2

1.3

—

nmol/l

—

Carcinoid syndrome

5.18

5.32

1.2

—

nmol/l

—

Psoriatic and enteropathic arthropathies

573

1.67

5.31

1.2

1.3

—

nmol/l

—

Benign leiomyoma with endometriosis

143

951

1.51

5.29

1.2

1.3

—

nmol/l

—

Lactose intolerance, other/unspecified

2.75

5.29

2.0

1.4

—

nmol/l

—

Female genital prolapse

223

881

1.41

5.29

1.3

—

nmol/l

—

Thiazolidinediones

499

1.72

5.26

1.3

—

nmol/l

—

Postmenopausal atrophic vaginitis

210

805

1.43

5.26

1.2

1.3

—

nmol/l

—

Ehlers-Danlos syndrome

3.75

5.25

1.1

1.2

—

nmol/l

—

Autoimmune thyroiditis

3.10

5.25

1.1

1.3

—

nmol/l

—

Pericarditis

132

2.45

5.23

1.7

1.3

—

nmol/l

—

Preparatory care for dialysis

176

2.24

5.21

1.2

1.3

—

nmol/l

—

Abnormal findings on diagnostic imaging of central nervous system

222

2.10

5.20

1.1

1.3

—

nmol/l

—

Examination and encounter for administrative purposes

311

1.91

5.20

1.5

1.4

—

nmol/l

—

Non-allergic asthma (mode), excluding more controls

127

818

1.54

5.19

1.4

1.3

—

nmol/l

—

Atopic dermatitis, strict definition with reimbursement

227

1583

1.38

5.19

1.3

—

nmol/l

—

Other Crohn's disease

312

1.91

5.16

1.2

1.4

—

nmol/l

—

Nontoxic single thyroid nodule

355

1.85

5.16

1.3

—

nmol/l

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

203

2.14

5.15

1.7

1.4

—

nmol/l

—

Abdominal aortic aneurysm (AAA)

268

1.97

5.13

1.1

1.3

—

nmol/l

—

Ulcer of lower limb, not elsewhere classified

109

687

1.60

5.12

1.2

1.3

—

nmol/l

—

IgA nephropathy (IgA glomerulonephritis)

2.70

5.11

1.1

1.3

—

nmol/l

—

Polycystic kidney disease

2.70

5.11

1.7

1.4

—

nmol/l

—

Anosmia

3.81

5.09

1.2

1.1

—

nmol/l

—

Other erythematous conditions

159

2.30

5.08

1.5

1.2

—

nmol/l

—

Effects of other external causes

110

2.58

5.07

1.4

1.3

—

nmol/l

—

Hyperplasia of prostate

212

848

1.41

5.06

1.5

1.4

—

nmol/l

—

Other abnormal findings of blood chemistry

218

2.09

5.05

1.2

1.4

—

nmol/l

—

Misadventures to patients during surgical and medical care

114

729

1.57

5.05

1.6

1.3

—

nmol/l

—

Blepharochalasis

236

1735

1.37

5.05

1.2

1.3

—

nmol/l

—

Cholecystitis

100

620

1.62

5.03

1.3

—

nmol/l

—

Fitting and adjustment of other devices

267

1757

1.34

5.03

1.3

—

nmol/l

—

Viral infections of the central nervous system, including avohilmo

358

1.83

5.03

1.4

1.3

—

nmol/l

—

Other and unspecified myopathies

387

1.80

5.02

1.3

—

nmol/l

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

484

1.71

5.00

1.3

—

nmol/l

—

Viral pneumonia

101

629

1.62

5.00

1.3

—

nmol/l

—

Mental and behavioural disorders due to opioids

154

2.30

4.98

1.5

1.4

—

nmol/l

—

Secondary polycythaemia

2.77

4.97

1.2

1.3

—

nmol/l

—

Alzheimer disease

108

1199

0.64

4.96

1.4

1.3

—

nmol/l

—

Symptoms and signs involving appearance and behaviour

5.59

4.96

1.2

1.5

—

nmol/l

—

Other menopausal disorders

215

857

1.40

4.96

1.3

—

nmol/l

—

ILD medications: azathioprine

112

717

1.57

4.94

1.3

—

nmol/l

—

Follow-up examination after treatment for malignant neoplasms

389

1.78

4.94

1.8

1.3

—

nmol/l

—

Cauda equina syndrome

3.41

4.92

1.8

1.3

—

nmol/l

—

Hypersomnia

3.41

4.92

1.5

1.3

—

nmol/l

—

Tuberous sclerosis 1

12.59

4.91

1.8

1.6

—

nmol/l

—

Lactose intolerance

106

2.58

4.90

2.0

1.4

—

nmol/l

—

Mental and behavioural disorders due to sedatives or hypnotics

311

1.88

4.89

1.4

—

nmol/l

—

Episcleritis

269

1.96

4.89

1.7

1.4

—

nmol/l

—

Polymyalgia rheumatica

103

649

1.60

4.88

1.2

1.3

—

nmol/l

—

Nontraumatic intracranial haemmorrhage

141

953

1.49

4.84

1.6

1.3

—

nmol/l

—

Disorders of pituitary gland, other and/or unspecified

6.75

4.83

1.5

1.2

—

nmol/l

—

Malignant neoplasm of bladder, including Hilmo

430

1.73

4.83

1.3

—

nmol/l

—

Crohn disease (strict definition, require KELA, min 2 HDR)

284

1.92

4.83

1.4

—

nmol/l

—

Monoamine oxidase A inhibitors

589

1.62

4.81

1.5

1.3

—

nmol/l

—

Injury of unspecified body region

356

1.81

4.81

1.5

1.3

—

nmol/l

—

Other and unspecified erythematous conditions

144

2.33

4.80

1.5

1.3

—

nmol/l

—

Alzheimer disease, including avohilmo

135

1376

0.68

4.78

1.4

1.3

—

nmol/l

—

Benign neoplasm of bone and articular cartilage

394

1.77

4.76

1.2

1.3

—

nmol/l

—

Magnesium deficiency

7.66

4.75

2.4

1.2

—

nmol/l

—

Chronic nephritic syndrome

151

2.28

4.75

1.1

1.3

—

nmol/l

—

Hirsutism in women

2.99

4.74

1.2

—

Acute lymphadenitis

258

1.96

4.74

1.2

1.3

—

nmol/l

—

Viral pneumonia (unknown virus, not influenza)

286

1.90

4.74

1.4

—

nmol/l

—

Crohn disease (strict definition, require KELA)

287

1.90

4.69

1.4

—

nmol/l

—

Panniculitis affecting regions of neck and back

133

2.36

4.68

1.3

1.4

—

nmol/l

—

Abnormal spermatozoa

486

1.68

4.67

1.5

1.3

—

nmol/l

—

Benign neoplasm: Brain, unspecified

6.36

4.66

1.4

1.2

—

nmol/l

—

Other adrenocortical overactivity

6.36

4.66

1.5

1.3

—

nmol/l

—

Hypertrophic cardiomyopathy

172

2.18

4.64

1.1

1.3

—

nmol/l

—

Glaucoma suspect

287

2200

1.31

4.63

1.2

1.3

—

nmol/l

—

Alzheimer’s disease, strict definition

1012

0.60

4.63

1.4

1.3

—

nmol/l

—

Infective dermatitis

566

1.62

4.57

1.5

1.3

—

nmol/l

—

Malignant neoplasm of digestive organs

286

1674

1.31

4.52

1.4

1.3

—

nmol/l

—

Other/unspecified disorders of vestibular function

174

2.15

4.52

1.2

1.3

—

nmol/l

—

Wide developmental disorders

110

2.47

4.51

1.1

1.4

—

nmol/l

—

Acute peritonitis

256

1.93

4.50

1.3

1.2

—

nmol/l

—

Decubitus ulcer and pressure area

242

1.96

4.49

1.2

1.3

—

nmol/l

—

Other cataract

329

1907

1.29

4.49

1.3

—

nmol/l

—

Malignant melanoma, including Hilmo

128

863

1.49

4.49

1.2

1.3

—

nmol/l

—

Asthma mixed form (mode), excluding more controls

175

2.13

4.44

1.4

1.3

—

nmol/l

—

Sulfonylureas

213

1245

1.36

4.44

1.4

1.3

—

nmol/l

—

Liquid cancers, including Hilmo

258

1727

1.32

4.41

1.4

1.3

—

nmol/l

—

Anaemia in chronic diseases classified elsewhere

2.59

4.41

1.1

1.3

—

nmol/l

—

Peripheral artery operations in Hilmo

486

1.65

4.41

1.2

1.3

—

nmol/l

—

Traumatic subarachnoid haemorrhage

112

2.43

4.40

1.4

1.5

—

nmol/l

—

Azathioprine

112

738

1.53

4.39

1.3

—

nmol/l

—

Fibroblastic disorders

158

1114

1.42

4.39

1.2

1.4

—

nmol/l

—

Galactorrhea

3.42

4.36

1.2

—

nmol/l

—

Non-allergic asthma (mode)

127

852

1.48

4.36

1.4

1.2

—

nmol/l

—

Spinal osteochondrosis

4.35

4.36

1.6

—

nmol/l

—

Benign neoplasm: Descending colon

331

1.80

4.35

1.5

1.3

—

nmol/l

—

Failure and rejection of transplanted organs and tissues

3.40

4.35

1.5

1.4

—

nmol/l

—

Atopic conjunctivitis

197

2.05

4.34

1.2

1.4

—

nmol/l

—

Other and unspecified rosacea

467

1.66

4.31

1.5

1.3

—

nmol/l

—

Thyrotoxicosis with toxic multinodular goitre

318

1.81

4.30

1.2

1.3

—

nmol/l

—

Allergic rhinitis

228

1691

1.34

4.29

1.2

1.3

—

nmol/l

—

Arterial embolism and thrombosis

191

2.06

4.29

1.3

—

nmol/l

—

Autism spe, excluding more controls

2.80

4.28

1.2

1.5

—

nmol/l

—

Other and unspecified trigeminal disorders

3.09

4.27

1.3

—

nmol/l

—

Vitamin B12 deficiency anaemia

461

1.66

4.24

1.3

—

nmol/l

—

Intussusception

2.60

4.24

1.1

1.2

—

Benign neoplasm: Skin of eyelid, including canthus

123

834

1.48

4.23

1.3

—

nmol/l

—

Perforation of tympanic membrane

462

1.66

4.22

1.2

1.4

—

nmol/l

—

Any dementia

157

1518

0.71

4.21

1.4

1.3

—

nmol/l

—

Haemangioma and lymphangioma, any site

463

1.65

4.19

1.4

1.3

—

nmol/l

—

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

2.71

4.19

1.1

1.3

—

nmol/l

—

Alzheimer’s disease (Late onset)

923

0.60

4.18

1.3

—

nmol/l

—

Other peripheral vascular diseases

365

1.74

4.18

1.4

1.3

—

nmol/l

—

Benign neoplasm of meninges

549

1.60

4.17

1.4

1.3

—

nmol/l

—

Redundant prepuce, phimosis and paraphimosis

131

887

1.46

4.16

1.3

1.4

—

nmol/l

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

2.85

4.15

1.1

1.3

—

nmol/l

—

Benign neoplasm: Cerebral meninges

503

1.62

4.15

1.4

1.3

—

nmol/l

—

Charcot foot

3.03

4.14

1.2

1.5

—

nmol/l

—

conjunctival haemorrhage

381

1.72

4.14

1.2

1.3

—

nmol/l

—

Agoraphobia

122

2.32

4.12

1.1

1.4

—

nmol/l

—

Any event in hilmo or specialist outpatient

+∞

4.12

2.4

0.0

—

nmol/l

—

Acute pancreatitis (for exclusion)

145

1020

1.43

4.11

1.2

1.3

—

nmol/l

—

Gastrointestinal stromal tumor and sarcoma

2.93

4.11

2.5

1.3

—

nmol/l

—

Presence of other devices

165

1169

1.39

4.08

1.2

1.3

—

nmol/l

—

Malignant melanoma

112

751

1.50

4.08

1.2

1.3

—

nmol/l

—

Myocardial infarction, unclassifiable

131

807

1.45

4.07

1.5

1.3

—

nmol/l

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

324

1.78

4.06

1.2

1.4

—

nmol/l

—

L04AD Calcineurin inhibitors

537

1.59

4.06

1.4

1.3

—

nmol/l

—

Hypertensive encephalopathy

5.89

4.05

1.3

1.6

—

nmol/l

—

Flat foot [pes planus] (acquired)

506

1.61

4.05

1.4

—

nmol/l

—

Asthma mixed form (mode)

182

2.05

4.04

1.4

—

nmol/l

—

Haemangioma, any site

437

1.66

4.04

1.4

1.3

—

nmol/l

—

Other noninflammatory disorders of vulva and perineum

483

1.63

4.04

1.4

1.3

—

nmol/l

—

Hidradenitis suppurativa

149

2.17

4.03

1.3

—

nmol/l

—

Scoliosis

339

1.75

4.03

1.4

1.3

—

nmol/l

—

Parkinson's disease, excluding more controls

479

1.60

4.01

1.5

1.4

—

nmol/l

—

Malignant neoplasm of pancreas

303

1.80

4.01

1.7

1.3

—

nmol/l

—

Herpesviral [herpes simplex] infections

586

1.56

4.00

1.4

1.3

—

nmol/l

—

Plantar fascial fibromatosis

492

1.62

4.00

1.2

1.3

—

nmol/l

—

Other and unspecified diseases of blood and blood-forming organs

105

2.42

4.00

1.4

1.3

—

nmol/l

—

Other and unspecified immunodeficiencies with predominantly antibody defects

3.09

4.00

1.0

1.3

—

nmol/l

—

189

2.02

4.00

1.2

—

nmol/l

—

Scleritis

3.08

3.99

1.1

1.3

—

nmol/l

—

Artificial joint re-operation

348

1.74

3.99

1.3

—

nmol/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

2.87

3.99

2.3

1.3

—

nmol/l

—

Carrier of infectious disease

2.51

3.98

1.3

1.2

—

Disorders of tooth development and eruption

121

670

1.48

3.98

1.3

—

nmol/l

—

Other pleural conditions

417

1.66

3.94

1.2

1.3

—

nmol/l

—

Causalgia

2.93

3.92

1.9

1.3

—

nmol/l

—

Ovarian dysfunction, other/unspecified

6.19

3.85

1.4

1.3

—

nmol/l

—

Somnolence, stupor and coma

152

2.12

3.85

1.4

1.3

—

nmol/l

—

Neurofibromatosis, type 2

12.95

3.83

1.8

1.4

—

nmol/l

—

Polyp of the female genital tract

218

927

1.34

3.83

1.3

—

nmol/l

—

Urethritis and urethral syndrome

2.46

3.83

1.4

1.3

—

nmol/l

—

Other abnormal immunological findings in serum

2.51

3.82

1.2

1.3

—

nmol/l

—

Papilloedema, unspecified

2.57

3.82

1.3

—

nmol/l

—

Degenerative diseases of the nervous system

137

1383

0.71

3.82

1.4

1.3

—

nmol/l

—

Hypertrichosis

2.57

3.82

1.2

1.3

—

Zoster [herpes zoster]

139

986

1.42

3.80

1.3

—

nmol/l

—

Impacted cerumen

562

1.56

3.80

1.3

1.4

—

nmol/l

—

Unspecified contracted kidney

4.77

3.80

1.2

1.6

—

nmol/l

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

140

995

1.41

3.79

1.6

1.3

—

nmol/l

—

Traumatic subdural haemorrhage

481

1.58

3.76

1.1

1.4

—

nmol/l

—

Benign neoplasm: Ascending colon

110

749

1.48

3.76

1.5

1.3

—

nmol/l

—

Benign neoplasm of other and unspecified sites

134

2.19

3.75

1.9

1.3

—

nmol/l

—

Chondrocostal junction syndrome [Tietze]

181

2.01

3.75

1.5

1.4

—

nmol/l

—

Psoriatic arthropathies

493

1.59

3.75

1.3

—

nmol/l

—

Disorders of magnesium metabolism

4.27

3.74

1.3

1.4

—

nmol/l

—

Vascular diseases of the intestine

134

2.18

3.74

1.2

1.3

—

nmol/l

—

Thyroiditis

355

1.70

3.74

1.3

—

nmol/l

—

Postmenopausal bleeding

202

787

1.35

3.72

1.2

1.3

—

nmol/l

—

Autoimmune hyperthyroidism

281

1.79

3.72

1.3

1.4

—

nmol/l

—

Speech disturbances, not elsewhere classified

417

1.64

3.70

1.3

—

nmol/l

—

Medial epicondylitis

182

2.00

3.70

1.0

1.4

—

nmol/l

—

Other factor of the environment

3.17

3.67

1.8

1.2

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

312

1.74

3.66

1.4

—

nmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

290

1.77

3.66

1.4

1.3

—

nmol/l

—

Dependent personality disorder

2.57

3.65

1.2

1.4

—

Crohn's disease of large intestine

232

1.87

3.65

1.2

1.4

—

nmol/l

—

Acute epiglottitis

2.91

3.65

1.0

1.4

—

nmol/l

—

Hallux valgus (acquired)

242

1337

1.30

3.63

1.3

—

nmol/l

—

Allergic contact dermatitis

105

714

1.48

3.62

1.1

1.3

—

nmol/l

—

Idiopathic urticaria

104

2.34

3.62

1.3

—

nmol/l

—

Parkinson's disease, strict definition, excluding more controls

448

1.59

3.62

1.4

—

nmol/l

—

Diagnoses used for exclusion with ILD

178

1327

1.35

3.61

1.3

—

nmol/l

—

Malignant neoplasm of skin, including Hilmo

384

2098

1.23

3.59

1.4

1.2

—

nmol/l

—

Eosinophilia

2.70

3.59

1.4

1.3

—

nmol/l

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

112

774

1.45

3.56

1.4

1.3

—

nmol/l

—

L04AC Interleukin inhibitors

315

1.73

3.56

1.2

1.4

—

nmol/l

—

Other disorders of central nervous system

3.10

3.55

1.4

1.5

—

nmol/l

—

L01XX Other antineoplastic agents

249

1.82

3.54

1.3

1.2

—

nmol/l

—

Rash and other nonspecific skin eruption

477

1.58

3.53

1.3

—

nmol/l

—

Congenital malformations of anterior segment of eye

3.99

3.53

1.8

1.5

—

nmol/l

—

Isolated growth hormone deficiency

6.31

3.53

1.0

1.3

—

nmol/l

—

Arthropathy in Crohn disease

3.96

3.52

1.1

1.3

—

nmol/l

—

Hallux rigidus

106

727

1.47

3.51

1.2

1.3

—

nmol/l

—

Malignant melanoma of skin, including Hilmo

103

703

1.47

3.50

1.2

1.3

—

nmol/l

—

Rhinophyma

4.70

3.47

1.1

1.5

—

nmol/l

—

Other and unspecified mononeuropathies, also in other diseases

106

2.29

3.47

1.3

—

nmol/l

—

Temporal arteritis

159

2.04

3.46

1.4

1.2

—

nmol/l

—

Endocarditis

132

2.14

3.46

1.6

1.3

—

nmol/l

—

Other diseases of gallbladder

187

1.94

3.44

1.3

—

nmol/l

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

3.61

3.44

3.5

1.2

—

nmol/l

—

Defects in the complement system

3.88

3.43

1.5

1.2

—

nmol/l

—

Convergence insufficiency and excess

3.03

3.43

1.4

1.2

—

nmol/l

—

Benign neoplasm of middle ear and respiratory system

349

1.67

3.42

1.5

1.3

—

nmol/l

—

Viral meningitis

153

2.05

3.42

1.2

1.4

—

nmol/l

—

Cardiomyopathies, Primary/intrinsic

481

1.57

3.41

1.4

—

nmol/l

—

Autism spe

2.46

3.39

1.2

1.3

—

nmol/l

—

Autism

2.46

3.39

1.2

1.3

—

nmol/l

—

Melanocytic naevi, other sites/unspecified

404

1.62

3.38

1.2

1.3

—

nmol/l

—

Sarcoidosis

100

685

1.47

3.36

1.2

1.3

—

nmol/l

—

Giant cell arteritis

182

1.94

3.35

1.4

1.2

—

nmol/l

—

Other orthopaedic follow-up care

269

1.76

3.33

1.3

—

nmol/l

—

Dementia

199

1767

0.77

3.33

1.3

—

nmol/l

—

Hereditary motor and sensory neuropathy

3.73

3.32

1.4

—

nmol/l

—

Benign neoplasm: Nasopharynx

3.73

3.32

1.1

1.4

—

nmol/l

—

Other contact dermatitis

383

1.63

3.31

1.2

1.3

—

nmol/l

—

Other coagulation defects

337

1.67

3.31

1.2

1.3

—

nmol/l

—

Giant cell arteritis with polymyalgia rheumatica

162

2.00

3.31

1.4

1.2

—

nmol/l

—

Benign neoplasm: Small intestine

169

1.97

3.30

1.2

1.3

—

nmol/l

—

Other immunodeficiencies

3.09

3.28

1.5

1.3

—

nmol/l

—

Methotrexate

102

705

1.45

3.27

1.2

1.3

—

nmol/l

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.82

3.27

1.5

1.2

—

nmol/l

—

Bursitis of shoulder

109

2.23

3.27

1.9

1.3

—

Use of memantine

1088

0.69

3.26

1.3

—

nmol/l

—

Use of other anti-dementia drugs

1088

0.69

3.26

1.3

—

nmol/l

—

Other specified/unspecified dorsopathies

129

2.11

3.25

1.4

—

nmol/l

—

Other and unspecified disorders of autonomic nervous system

5.55

3.23

1.4

1.5

—

nmol/l

—

Benign neoplasm: Vulva

2.30

3.22

1.5

1.3

—

nmol/l

—

Other necrotizing vasculopathies (FG)

272

1.74

3.22

1.4

1.3

—

nmol/l

—

Hypothyroidism due to medicaments and other exogenous substances

2.92

3.22

1.3

1.4

—

nmol/l

—

Malignant neoplasm of skin

362

2013

1.22

3.21

1.3

1.2

—

nmol/l

—

Seborrhoeic dermatitis

489

1.54

3.21

1.4

1.3

—

nmol/l

—

Subacute thyroiditis

171

1.95

3.20

1.2

—

nmol/l

—

Lichen planus

103

718

1.44

3.18

1.3

1.4

—

nmol/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

349

1.65

3.18

1.3

1.4

—

nmol/l

—

Trigger finger

107

751

1.43

3.18

1.1

1.3

—

nmol/l

—

Viral infections of the central nervous system

334

1.66

3.16

1.3

—

nmol/l

—

Striae atrophicae

3.01

3.16

1.3

—

nmol/l

—

All influenza (not pneumonia)

101

702

1.44

3.16

1.7

1.3

—

nmol/l

—

Fall on and from ladder

319

1.67

3.15

1.2

1.4

—

nmol/l

—

Speech and linguistic disorders, excluding more controls

270

1.71

3.14

1.2

1.3

—

nmol/l

—

Acidosis

2.50

3.14

1.7

1.4

—

nmol/l

—

Tobacco use

230

1.80

3.12

1.2

1.3

—

nmol/l

—

Amiodarone users

429

1.57

3.11

1.4

1.3

—

nmol/l

—

105

2.22

3.11

1.4

—

nmol/l

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

7.92

3.10

1.2

2.0

—

nmol/l

—

Benign neoplasm: Central nervous system, other parts/unspecified

5.24

3.10

2.3

1.6

—

nmol/l

—

Tongue abnormality

298

1.69

3.10

1.2

1.3

—

nmol/l

—

Other specified disorders of kidney and ureter

132

2.07

3.08

2.4

1.3

—

nmol/l

—

Crohn disease (strict definition, all UC cases excluded)

224

1.80

3.07

1.4

—

nmol/l

—

Other and unspecified injuries of ankle and foot

181

1.89

3.06

1.1

1.4

—

nmol/l

—

Bronchiectasis

353

1.63

3.05

1.4

1.3

—

nmol/l

—

Kela reimbursement Agammaglobulinemia (D80-84)

3.42

3.05

1.2

1.4

—

nmol/l

—

Dementia, including avohilmo

221

1908

0.79

3.04

1.3

—

nmol/l

—

Myositis

106

2.20

3.04

1.1

1.3

—

nmol/l

—

Tibial collateral bursitis [Pellegrini-Stieda]

3.40

3.04

1.4

1.3

—

nmol/l

—

Paralytic ileus

126

2.08

3.03

1.5

1.4

—

nmol/l

—

Congenital iodine-deficiency syndrome/hypothyroidism

113

2.15

3.02

1.3

1.2

—

nmol/l

—

Hepatomegaly and splenomegaly, not elsewhere classified

3.62

3.01

1.3

—

Pustulosis palmaris et plantaris

211

1.82

3.01

1.2

1.4

—

nmol/l

—

Spasmodic torticollis

154

1.97

3.01

2.0

1.3

—

nmol/l

—

Uterine polyps

201

908

1.30

2.99

1.3

—

nmol/l

—

Other neurotic disorders

197

1.84

2.98

1.5

1.3

—

nmol/l

—

Sudden idiopathic hearing loss

474

1.53

2.97

1.3

—

nmol/l

—

Congenital malformations of uterus and cervix

2.49

2.97

1.5

1.2

—

nmol/l

—

5-aminosalicylic acid

147

1101

1.34

2.97

1.2

1.3

—

nmol/l

—

Bronchitis, not specified as acute or chronic

379

1.59

2.97

1.6

1.4

—

nmol/l

—

Other congenital malformations of skin

176

1.89

2.96

1.2

1.3

—

nmol/l

—

Polyarthritis, unspecified

162

1.93

2.96

1.3

1.4

—

nmol/l

—

Use of rivastigmine

729

0.60

2.95

1.3

—

nmol/l

—

Other necrotizing vasculopathies

333

1.63

2.95

1.3

—

nmol/l

—

Injury of muscle and tendon at shoulder and upper arm level

257

2071

1.24

2.94

1.3

—

nmol/l

—

Left bundle-branch block

318

1.65

2.93

1.2

1.4

—

nmol/l

—

Cholesteatoma of external ear

3.53

2.93

1.2

1.4

—

Entropion and trichiasis of eyelid

349

1.61

2.93

1.2

1.3

—

nmol/l

—

Fracture of neck

250

1.73

2.92

1.2

1.3

—

nmol/l

—

Benign neoplasm: Brain, infratentorial

3.83

2.92

4.6

1.6

—

nmol/l

—

Pre-eclampsia superimposed on chronic hypertension

4.22

2.91

1.0

1.2

—

Perioral dermatitis

2.24

2.91

1.4

1.2

—

nmol/l

—

Arterial embolism and thrombosis of lower extremity artery

108

2.15

2.91

1.3

—

nmol/l

—

Other noninflammatory disorders of vagina

397

1.57

2.91

1.2

1.3

—

nmol/l

—

Colorectal neuroendocrine tumor and carcinoma

2.63

2.89

1.5

1.4

—

nmol/l

—

Renal cell carcinoma of kidney

122

2.07

2.88

2.4

1.3

—

nmol/l

—

Other congenital malformations of nervous system

3.22

2.87

1.0

1.4

—

nmol/l

—

Exophthalmic conditions

3.22

2.87

1.0

1.3

—

nmol/l

—

L02BA Anti-estrogens

1016

0.67

2.86

1.7

1.3

—

nmol/l

—

Other/unspecified enthesopathies, not elsewhere classified

375

1.58

2.86

1.1

1.3

—

nmol/l

—

Spinal instabilities

2.21

2.84

1.2

—

nmol/l

—

Arnold-Chiari syndrome

3.41

2.83

1.0

1.4

—

nmol/l

—

Other/unspecified synovitis and tenosynovitis

553

1.47

2.82

1.2

1.3

—

nmol/l

—

Ulcerative ileocolitis

172

1.88

2.82

1.2

1.5

—

nmol/l

—

Other specified and unspecified retinal disorders

144

1.96

2.81

1.8

1.4

—

nmol/l

—

Disorders of iron metabolism

2.50

2.81

1.3

1.4

—

Use of donepezil

909

0.66

2.81

1.3

—

nmol/l

—

Explicit fungal Sepsis, including avohilmo

4.01

2.80

2.1

1.5

—

nmol/l

—

Malignant melanoma of skin

571

1.46

2.79

1.2

1.3

—

nmol/l

—

Invasive ventilation

315

1.63

2.79

1.9

1.3

—

nmol/l

—

Congenital malformations of the nervous system

2.29

2.78

1.4

1.2

—

nmol/l

—

Amenorrhoea

269

1.68

2.78

1.6

1.2

—

nmol/l

—

Lordosis

8.68

2.78

1.2

—

Schizophrenia or delusion, excluding more controls

194

1505

1.28

2.77

1.3

—

nmol/l

—

Allergic urticaria

386

1.56

2.77

1.1

1.3

—

nmol/l

—

Other and unspecified local infections of skin and subcutaneous tissue

458

1.51

2.77

1.4

1.3

—

nmol/l

—

Other disorders of Eustachian tube

145

1.95

2.76

1.4

1.3

—

Nontoxic diffuse goitre

138

1.98

2.76

1.2

—

nmol/l

—

Sleep disorders, other/unspecified

145

1.95

2.76

1.2

1.4

—

nmol/l

—

Alcohol-induced chronic pancreatitis

270

1.68

2.75

1.4

1.3

—

nmol/l

—

Flatulence and related conditions

3.29

2.74

1.5

1.1

—

nmol/l

—

Heart failure and hypertrophic cardiomyopathy

2.40

2.74

1.2

1.3

—

nmol/l

—

Pleural effusion

698

1.41

2.73

1.4

1.3

—

nmol/l

—

Sequelae of injuries of head

218

1.76

2.73

1.2

1.3

—

nmol/l

—

Suppurative and necrotic conditions of lower respiratory tract

218

1.76

2.73

1.2

1.4

—

nmol/l

—

Other specified congenital malformation syndromes affecting multiple systems

2.74

2.72

1.2

1.5

—

nmol/l

—

Neovascular glaucoma

160

1.89

2.72

1.7

1.3

—

nmol/l

—

Pyogenic arthritis

271

1.67

2.71

1.8

1.4

—

nmol/l

—

Other bursopathies

641

1.43

2.71

1.2

1.3

—

nmol/l

—

Abnormal findings on examination of urine, without diagnosis

182

1.83

2.70

1.8

1.3

—

nmol/l

—

Visual field defects

389

1.55

2.69

1.2

1.3

—

nmol/l

—

Background retinopathy and retinal vascular changes

2.31

2.69

1.6

1.2

—

nmol/l

—

Allergic contact dermatitis due to drugs in contact with skin

2.20

2.69

1.2

1.3

—

nmol/l

—

Chalazion

543

1.46

2.68

1.1

1.3

—

nmol/l

—

Maltreatment syndromes

197

1.79

2.68

1.2

1.4

—

nmol/l

—

Bell's palsy

560

1.45

2.67

1.2

1.4

—

nmol/l

—

Ethmoidectomy

660

1.42

2.66

1.2

1.3

—

nmol/l

—

Other diseases of arteries and capillaries

390

1.55

2.66

1.2

1.3

—

nmol/l

—

Liquid cancers

194

1450

1.27

2.66

1.4

1.3

—

nmol/l

—

Pedal cyclist injured in other and unspecified transport accidents

561

1.45

2.65

1.2

1.3

—

nmol/l

—

Arthropathic psoriasis

553

1.45

2.64

1.3

1.4

—

nmol/l

—

Contusion of toe(s) without damage to nail

106

2.10

2.64

1.5

1.3

—

nmol/l

—

Psoriatic arthropathies, ICD10

537

1.46

2.64

1.3

—

nmol/l

—

Poisoning by medicine, drug-induced

2.59

2.63

1.1

1.4

—

nmol/l

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.58

2.63

1.4

1.3

—

nmol/l

—

Other disorders of penis

391

1.54

2.62

1.2

1.3

—

nmol/l

—

Other local infections of skin and subcutaneous tissue

497

1.48

2.61

1.4

1.3

—

nmol/l

—

Asthma and opportunity respiratory infection

199

1.77

2.61

1.5

1.3

—

nmol/l

—

Other psoriatic arthropathies

522

1.46

2.60

1.3

—

nmol/l

—

Factitial dermatitis

4.12

2.59

1.0

1.5

—

nmol/l

—

Lichen planus, including avohilmo

148

1135

1.31

2.59

1.4

1.3

—

nmol/l

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

4.11

2.59

1.0

1.8

—

Acromegaly and pituitary gigantism

4.09

2.59

1.3

1.2

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

3.12

2.58

1.2

—

Relapsing fevers

7.52

2.58

1.4

1.0

—

Benign neoplasm: Rectosigmoid junction

163

1.86

2.58

1.2

—

nmol/l

—

Glaucoma secondary to other eye disorders

163

1.86

2.58

1.7

1.3

—

nmol/l

—

Benign intracranial hypertension

3.11

2.58

1.2

—

Residual foreign body in soft tissue

207

1.75

2.58

1.3

1.4

—

nmol/l

—

Convalescence

260

1.67

2.58

1.1

1.3

—

nmol/l

—

Alkalosis

7.46

2.58

1.0

1.3

—

Fluid overload

5.67

2.57

1.2

1.1

—

Other diseases of peritoneum

200

1.76

2.57

1.3

—

nmol/l

—

Postprocedural disorders of digestive system, not elsewhere classified

142

1.92

2.56

1.0

1.2

—

nmol/l

—

Universal erythroderma, KELA reimbursement

2.90

2.56

1.3

—

nmol/l

—

Other obstructive and reflux uropathy

142

1.91

2.56

1.8

1.3

—

nmol/l

—

Patellar tendinitis

2.89

2.55

1.2

1.5

—

nmol/l

—

Other congenital malformations of peripheral vascular system

2.64

2.55

1.2

1.3

—

nmol/l

—

Malnutrition

2.29

2.52

2.8

1.3

—

nmol/l

—

Amyloidosis

2.29

2.52

1.1

1.3

—

nmol/l

—

Unspecified chronic bronchitis

115

2.01

2.51

1.1

1.4

—

Hereditary hypogammaglobulinemia

4.55

2.51

1.1

—

nmol/l

—

Other disorders of male genital organs

136

1.93

2.51

1.4

1.5

—

nmol/l

—

Biomechanical lesions, not elsewhere classified

232

1.69

2.49

1.1

1.4

—

nmol/l

—

Other hearing loss

182

1395

1.27

2.49

1.2

1.3

—

nmol/l

—

Unspecified renal colic

3.91

2.48

1.4

1.6

—

nmol/l

—

Other infectious diseases, including avohilmo

405

1.51

2.48

1.2

1.3

—

nmol/l

—

Myasthenia gravis

2.41

2.48

1.2

1.3

—

nmol/l

—

Other facial nerve disorders

116

2.00

2.46

1.3

—

nmol/l

—

Ankylosing hyperostosis [Forestier]

2.71

2.46

1.1

1.2

—

nmol/l

—

Chronic conjunctivitis

130

1.94

2.46

1.5

1.4

—

nmol/l

—

Benign neoplasm: Anus and anal canal

123

1.97

2.46

1.5

1.3

—

nmol/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

350

1.55

2.45

1.2

1.4

—

nmol/l

—

Spermatocele

256

1.65

2.45

1.3

—

nmol/l

—

Other and unspecified mood [affective] disorders

287

1.61

2.45

1.1

1.4

—

nmol/l

—

Cerebral atherosclerosis

2.70

2.45

1.2

1.3

—

nmol/l

—

Polycythaemia vera

152

1.86

2.44

1.1

1.3

—

nmol/l

—

Ptosis of eyelid

563

1.43

2.43

1.2

1.3

—

nmol/l

—

Nonpyogenic thrombosis of intracranial venous system

2.95

2.43

1.2

1.3

—

nmol/l

—

Carcinoma in situ, bladder

138

1.90

2.42

1.1

1.3

—

nmol/l

—

Disorder of pancreatic internal secretion, other and/or unspecified

3.41

2.41

1.0

1.5

—

Transplanted organ and tissue status

465

1.47

2.41

1.4

1.3

—

nmol/l

—

Endometriosis of rectovaginal septum and vagina

376

1.52

2.40

1.2

—

nmol/l

—

Calculus of lower urinary tract

182

1.77

2.40

1.2

1.3

—

nmol/l

—

FESS (DNB20)

632

1.40

2.39

1.2

1.3

—

nmol/l

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

385

1.52

2.38

1.6

1.3

—

nmol/l

—

Other and unspecified disorders of pigmentation

3.10

2.38

1.6

1.4

—

Orchitis and epididymitis

345

1.54

2.37

1.2

1.3

—

nmol/l

—

Other and unspecified follicular disorders

183

1.76

2.36

1.3

1.5

—

nmol/l

—

Benign neoplasm: Other and unspecified parts of small intestine

2.29

2.36

1.2

1.3

—

nmol/l

—

Female infertility, associated with anovulation

290

1.59

2.36

1.6

1.3

—

nmol/l

—

Ulcer of oesophagus

259

1.63

2.36

1.8

1.3

—

nmol/l

—

Pollen allergy

123

920

1.32

2.35

1.2

1.3

—

nmol/l

—

Other otitis externa (chronic)

330

1.56

2.35

1.1

1.4

—

nmol/l

—

Pneumonitis due to solids and liquids

314

1.57

2.35

1.7

1.3

—

nmol/l

—

Coxarthrosis, primary

434

3112

1.16

2.35

1.3

—

nmol/l

—

Acute generalized exanthematous pustulosis

191

1.74

2.34

1.7

1.3

—

nmol/l

—

Other conjunctival vascular disorders and cysts

2.11

2.34

1.2

—

nmol/l

—

Other secondary gonarthrosis

252

1.64

2.34

1.2

1.4

—

nmol/l

—

Vaginal lichen planus

3.30

2.33

1.4

1.2

—

nmol/l

—

Childhood asthma (age<16), excluding more controls

363

1.47

2.33

1.3

—

nmol/l

—

Benign neoplasm: Long bones of lower limb

140

1.87

2.33

1.3

—

nmol/l

—

Hemiplegia

214

1.69

2.32

1.2

1.4

—

nmol/l

—

Other infectious diseases

331

1.55

2.32

1.3

—

nmol/l

—

Simple and mucopurulent chronic bronchitis

140

1.87

2.32

1.2

1.4

—

nmol/l

—

Pneumothorax

276

1.60

2.31

1.5

1.3

—

nmol/l

—

Ulcer of vagina/vulva

119

1.95

2.31

1.1

1.3

—

nmol/l

—

Other disorders of thyroid

2.41

2.31

1.3

1.4

—

nmol/l

—

Disturbances of smell and taste

192

1.73

2.31

1.2

1.3

—

nmol/l

—

Malignant neoplasm of oropharynx

2.40

2.30

2.1

1.3

—

nmol/l

—

Unspecified misadventure during surgical and medical care

261

1.62

2.30

1.6

1.3

—

nmol/l

—

Melanoma in situ of other and unspecified parts of face

2.50

2.29

1.0

1.2

—

nmol/l

—

Migraine with aura, drug-induced

2.80

2.29

1.4

1.2

—

nmol/l

—

Explicit fungal Sepsis

3.55

2.29

2.3

1.5

—

nmol/l

—

Somnolence

2.59

2.28

1.7

1.3

—

nmol/l

—

Intercostal neuropathy

3.54

2.28

1.1

1.5

—

Dementia in Alzheimer disease

693

0.67

2.28

1.4

1.3

—

nmol/l

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

301

1.57

2.27

1.1

1.3

—

nmol/l

—

Synovial cyst of popliteal space [Baker]

333

1.54

2.27

1.3

—

nmol/l

—

Cardiomyopathy (excluding other)

538

1.42

2.26

1.4

—

nmol/l

—

Ulcerative enterocolitis

113

1.96

2.26

1.5

1.3

—

nmol/l

—

Hydrocele

414

1.48

2.26

1.3

—

nmol/l

—

Paraplegia, diplegia of upper limbs

2.18

2.26

1.3

—

nmol/l

—

Retinal vascular occlusion

530

1.42

2.25

1.2

1.3

—

nmol/l

—

Congenital malformations of eye, ear, face and neck

278

1.59

2.25

1.5

1.3

—

nmol/l

—

Carcinoma in situ of other and unspecified sites

149

1.83

2.25

1.3

—

nmol/l

—

Wet age-related macular degeneration

108

781

1.34

2.24

1.2

1.3

—

nmol/l

—

Osteitis due to dental implant

2.75

2.23

1.0

1.4

—

nmol/l

—

Endometriosis in cutaneous scar

5.72

2.23

1.4

1.1

—

nmol/l

—

Volvulus

2.06

2.22

2.2

1.2

—

nmol/l

—

Dermatophytosis

701

1.36

2.22

1.5

1.3

—

nmol/l

—

Amputation of ankle bones

2.21

2.22

1.1

1.2

—

nmol/l

—

Acute posthaemorrhagic anaemia

128

1.89

2.22

1.8

1.3

—

nmol/l

—

Valvular operations

557

1.40

2.21

1.6

1.3

—

nmol/l

—

Malignant neoplasm of tonsil

2.44

2.21

2.2

1.3

—

nmol/l

—

L02BG Aromatase inhibitors

166

2046

0.80

2.21

1.4

1.3

—

nmol/l

—

Family history of other conditions

2.44

2.21

2.8

1.1

—

nmol/l

—

Malignant neoplasm of renal pelvis, including Hilmo

2.54

2.20

1.1

1.3

—

nmol/l

—

Unspecified urinary incontinence

458

1.45

2.20

1.2

1.3

—

nmol/l

—

Malignant neoplasm of tonsil and base of tongue

2.15

2.20

1.9

1.4

—

nmol/l

—

Anuria and oliguria

3.40

2.20

1.0

1.5

—

nmol/l

—

Other rupture of muscle

3.40

2.20

1.5

1.8

—

nmol/l

—

Alcohol dependence

168

1342

1.26

2.18

1.2

1.3

—

nmol/l

—

Senility

3.36

2.18

1.1

1.3

—

nmol/l

—

Thyrotoxicosis factitia

4.45

2.18

1.3

—

Pustular psoriasis

242

1.62

2.17

1.2

1.4

—

nmol/l

—

Other and unspecified disorders of binocular movement

3.77

2.17

1.4

1.2

—

nmol/l

—

Other other unspecified disorders of the circulatory system

151

1.80

2.17

1.3

—

nmol/l

—

Carcinoma in situ of skin of upper limb, including shoulder

101

2.00

2.16

2.3

1.2

—

nmol/l

—

Gangrene, not elsewhere classified

3.75

2.16

1.0

1.2

—

nmol/l

—

HSIL lesion of the vagina

2.33

2.16

1.1

1.2

—

Unspecified threat to breathing

2.82

2.15

1.1

1.4

—

nmol/l

—

Sequelae of other external causes

259

1.59

2.12

1.6

1.3

—

nmol/l

—

Olecranon bursitis

259

1.59

2.12

1.2

1.3

—

nmol/l

—

Malignant neoplasm of prostate

141

649

1.29

2.12

1.5

1.3

—

nmol/l

—

Amyloidosis, other/unspecified

2.23

2.12

1.1

1.3

—

nmol/l

—

Anomalies of pupillary function

2.02

2.12

1.6

1.4

—

nmol/l

—

Myocardial infarction, with ST-elevation

724

1.34

2.11

1.3

—

nmol/l

—

Any dementia, excluding more controls

151

1305

0.79

2.11

1.4

1.3

—

nmol/l

—

Lesion of femoral nerve

3.26

2.11

1.1

1.4

—

358

0.53

2.11

1.3

1.4

—

nmol/l

—

Relapsing fevers, including avohilmo

5.21

2.09

1.4

1.8

—

Alopecia universalis

5.18

2.09

1.2

2.0

—

Lifestyle-related condition

2.60

2.09

2.0

1.2

—

Vertigo of central origin

2.29

2.09

1.0

1.3

—

nmol/l

—

Henoch-Schönlein purpura nephritis (HSPN)

5.14

2.09

1.0

2.0

—

nmol/l

—

Osteonecrosis

308

1.54

2.09

1.4

1.3

—

nmol/l

—

Blepharospasm

2.75

2.08

1.1

1.3

—

nmol/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

170

1369

1.25

2.08

1.4

1.3

—

nmol/l

—

Other inflammatory liver diseases

292

1.55

2.08

1.2

1.3

—

nmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

718

1.34

2.08

1.4

1.3

—

nmol/l

—

Other benign neoplasms of connective and other soft tissue

472

1.43

2.08

1.2

1.3

—

nmol/l

—

Malignant neoplasm of colon, including Hilmo

117

896

1.30

2.08

1.3

—

nmol/l

—

Retinal vascular disorders

539

1.40

2.08

1.2

1.3

—

nmol/l

—

Seronegative rheumatoid arthritis

590

1.38

2.07

1.3

—

nmol/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

439

1.44

2.07

1.2

1.3

—

nmol/l

—

Childhood asthma (age<16)

373

1.43

2.06

1.3

—

nmol/l

—

Isolated proteinuria

110

1.93

2.06

1.1

1.3

—

nmol/l

—

Lesion of plantar nerve

317

1.52

2.06

1.3

—

nmol/l

—

Abscess of lung

2.35

2.06

1.4

—

nmol/l

—

Obsessive-compulsive disorder

261

1.58

2.05

1.4

1.3

—

nmol/l

—

Other and unspecified glaucoma

301

1.54

2.05

1.3

—

nmol/l

—

Other and unspecified vascular occlusions

415

1.45

2.05

1.2

1.3

—

nmol/l

—

Other disorders of the genitourinary system

720

1.34

2.05

1.2

1.3

—

nmol/l

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

169

1.73

2.05

1.4

1.2

—

nmol/l

—

Basal cell carcinoma

307

1779

1.18

2.04

1.3

—

nmol/l

—

Nonischemic cardiomyopathy

432

1.44

2.03

1.3

—

nmol/l

—

Female infertility

188

913

1.24

2.03

1.2

1.3

—

nmol/l

—

Pleural plaque

318

1.52

2.03

1.4

1.3

—

nmol/l

—

Myotonic disorders

3.13

2.02

1.0

1.5

—

nmol/l

—

Basal cell carcinoma, including Hilmo

318

1837

1.17

2.02

1.3

1.2

—

nmol/l

—

Outcome of delivery

512

0.69

2.02

1.2

1.3

—

nmol/l

—

Sequelae of injuries of upper limb

500

1.41

2.02

1.5

1.3

—

nmol/l

—

Deficiency of other B group vitamins

2.07

2.02

1.2

—

nmol/l

—

Other congenital malformations of face and neck

111

1.91

2.01

1.1

1.3

—

nmol/l

—

Other disorders of pigmentation

208

1.65

2.01

1.5

1.4

—

nmol/l

—

Meralgia paraesthetica

140

1.80

2.01

1.2

1.3

—

nmol/l

—

Benign neoplasm: Other parts of oropharynx

2.86

2.01

1.9

1.3

—

nmol/l

—

Iliotibial band syndrome

2.85

2.01

1.3

1.6

—

nmol/l

—

Presbyopia

393

1.46

1.99

1.7

1.3

—

nmol/l

—

Primary ovarian failure

2.17

1.99

1.2

—

nmol/l

—

Seborrhoeic keratosis

181

1476

1.23

1.99

1.3

—

nmol/l

—

Sequelae of injuries of neck and trunk

126

1.84

1.99

1.2

1.3

—

nmol/l

—

malignant neoplasm of male genital organs

146

694

1.27

1.98

1.5

1.3

—

nmol/l

—

Endovascular or surgical operations to intracerebral aneurysms

288

1.54

1.98

1.3

1.2

—

nmol/l

—

Hypertrophic disorders of skin

272

1.55

1.98

1.3

—

nmol/l

—

Other diseases of spinal cord

119

1.86

1.98

1.3

—

nmol/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

171

1.71

1.97

1.2

1.3

—

nmol/l

—

Malignant neoplasm of prostate, including Hilmo

143

665

1.27

1.96

1.5

1.3

—

nmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

411

1.44

1.96

1.4

1.3

—

nmol/l

—

Ankylosing spondylitis

337

1.49

1.96

1.3

—

nmol/l

—

Malignant neoplasm of retroperitoneum and peritoneum

2.62

1.96

2.7

1.2

—

nmol/l

—

Hypertrophic scar

241

1.59

1.96

1.2

1.3

—

nmol/l

—

Autoimmune hepatitis, wide definition

202

1.64

1.96

1.2

1.3

—

nmol/l

—

Other congenital malformations of intestine, including avohilmo

2.60

1.95

2.2

1.3

—

nmol/l

—

Mild or no visual impairment, binocular

3.84

1.95

1.2

1.3

—

Tracheo-bronchomalasia

3.83

1.95

1.5

1.4

—

Psoas tendinitis

3.82

1.95

1.0

1.1

—

Delayed puberty

3.80

1.94

1.2

1.3

—

nmol/l

—

2.77

1.94

1.2

1.3

—

Specific development disorders of scholastic skills

146

1.75

1.94

1.2

1.3

—

nmol/l

—

Premenstrual syndrome

2.47

1.94

1.2

—

nmol/l

—

Melanoma in situ

195

1.65

1.93

1.2

1.3

—

nmol/l

—

Benign neoplasm of thyroid gland

157

1.74

1.93

1.5

1.3

—

nmol/l

—

Other specified disorders of external ear

142

1.77

1.93

1.3

1.4

—

nmol/l

—

Sacrococcygeal disorders, not elsewhere classified

120

1.85

1.93

1.5

1.4

—

nmol/l

—

Unspecified privation

513

1.39

1.93

1.2

1.3

—

nmol/l

—

Idiopathic gout

396

1.45

1.93

1.2

1.3

—

nmol/l

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

298

1.52

1.92

1.7

1.4

—

nmol/l

—

Use of galantamine

308

0.52

1.92

2.0

1.3

—

nmol/l

—

Disorder of thyroid, unspecified

2.27

1.92

1.3

—

nmol/l

—

Discitis, unspecified

2.27

1.92

1.0

1.3

—

nmol/l

—

Macular pucker

108

833

1.30

1.91

1.3

—

nmol/l

—

Transient global amnesia

489

1.40

1.91

1.3

—

nmol/l

—

Biological medicines for asthma

1.98

1.91

1.2

—

nmol/l

—

Torsion of ovary, ovarian pedicle and fallopian tube

2.02

1.91

1.2

—

nmol/l

—

Mastocytosis

3.26

1.89

1.4

1.5

—

nmol/l

—

Congenital deformities of feet, including avohilmo

158

1.72

1.89

1.2

1.4

—

nmol/l

—

Malignant neoplasm of colon

721

1.32

1.89

1.3

—

nmol/l

—

Amputation

398

1.44

1.88

1.2

1.4

—

nmol/l

—

Benign neoplasm: Larynx

114

1.86

1.88

2.0

1.3

—

nmol/l

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

300

1.51

1.87

1.6

1.3

—

nmol/l

—

Heterophoria

374

1.45

1.86

1.4

1.3

—

nmol/l

—

Open wound of forearm

424

1.42

1.86

1.3

—

nmol/l

—

Retinal haemorrhage

100

1.92

1.86

1.2

1.3

—

nmol/l

—

Infection of intervertebral disc (pyogenic)

2.42

1.86

1.3

1.4

—

nmol/l

—

Other symptoms and signs involving general sensations and perceptions

159

1.71

1.85

1.3

—

nmol/l

—

Other arterial embolism and thrombosis

1.99

1.85

1.2

1.3

—

nmol/l

—

Other and unspecified paralytic syndromes

2.23

1.85

1.1

1.3

—

nmol/l

—

Achalasia of cardia

2.23

1.85

3.2

1.2

—

Enterocolitis due to Clostridium difficile

492

1.39

1.85

1.2

1.3

—

nmol/l

—

Other disorders of optic [2nd] nerve and visual pathways

277

1.52

1.84

1.2

1.4

—

nmol/l

—

Other and unspecified cicatricial alopecia

4.31

1.84

1.8

1.1

—

Other secondary coxarthrosis

152

1.72

1.84

1.6

1.3

—

nmol/l

—

Vestibular neuronitis

434

1.41

1.83

1.2

1.3

—

nmol/l

—

Other specified/unspecified hearing loss

409

1.42

1.83

1.1

1.3

—

nmol/l

—

Disorder of the sleep-wake schedule

2.14

1.83

1.4

1.3

—

nmol/l

—

Systemic sclerosis (FG)

108

1.87

1.82

1.3

1.4

—

nmol/l

—

Generalized skin eruption due to drugs and medicaments

160

1.70

1.82

1.7

1.3

—

nmol/l

—

Use of antiglaucoma preparations and miotics

343

1.46

1.82

1.4

1.3

—

nmol/l

—

Calcific tendinitis of shoulder

278

1.52

1.82

1.2

1.4

—

nmol/l

—

Secondary uncertain malignant neoplasm

622

1.34

1.81

1.2

1.3

—

nmol/l

—

Other abnormal findings in urine

2.29

1.81

2.8

1.2

—

nmol/l

—

Burn and corrosion confined to eye and adnexa

1.93

1.81

1.2

1.4

—

nmol/l

—

Common variable immunodeficiency

2.82

1.81

1.1

1.4

—

nmol/l

—

Other appendicitis

385

1.43

1.81

1.2

1.4

—

nmol/l

—

Malignant neoplasm, without specification of site, including Hilmo

191

1.63

1.80

1.5

1.4

—

nmol/l

—

Morphin

2.02

1.80

1.6

1.3

—

Disorders of puberty

2.78

1.79

1.1

1.2

—

nmol/l

—

Vasculitis limited to skin, not elsewhere classified

109

1.85

1.78

1.5

1.3

—

nmol/l

—

6-mercaptopurine

131

1.77

1.78

1.2

1.3

—

nmol/l

—

Malignant neoplasm of mesothelium and soft tissue

169

1.67

1.77

1.6

1.3

—

nmol/l

—

malignant neoplasm of male genital organs, including Hilmo

148

714

1.25

1.77

1.5

1.3

—

nmol/l

—

Cervical polyps

522

1.37

1.77

1.1

1.2

—

nmol/l

—

Other condition

747

1.30

1.76

1.2

1.3

—

nmol/l

—

ILD-related respiratory insufficiency

124

1.79

1.76

2.0

1.3

—

nmol/l

—

Pleural plaque without asbestos

124

1.79

1.76

1.7

1.2

—

nmol/l

—

Herpesviral keratitis and keratoconjunctivitis

185

1.63

1.76

1.5

1.4

—

nmol/l

—

Superficial injury of neck

2.05

1.76

1.1

1.4

—

nmol/l

—

2.04

1.75

1.5

1.3

—

nmol/l

—

Benign neoplasm: Connective and other soft tissue, unspecified

2.26

1.75

1.3

—

nmol/l

—

Other specified and unspecified disorders of eyelid

2.25

1.75

1.2

1.3

—

nmol/l

—

Endometriosis of intestine

2.24

1.74

1.1

—

Other diseases of biliary tract

405

1.41

1.74

1.2

1.3

—

nmol/l

—

Protein-energy malnutrition of moderate and mild degree

2.70

1.73

4.6

1.6

—

Other congenital malformations of limb(s)

2.96

1.73

4.0

1.3

—

nmol/l

—

Malignant neoplasm of thymus

3.95

1.73

1.0

1.7

—

nmol/l

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

3.95

1.73

2.8

1.5

—

nmol/l

—

Inflammatory disease of cervix uteri

323

1.46

1.72

1.3

—

nmol/l

—

Exclusion endpoint for clefts

2.15

1.71

1.2

1.4

—

nmol/l

—

Golimumab

171

1.65

1.71

1.3

—

nmol/l

—

Loose body in joint

1.93

1.70

1.1

1.6

—

nmol/l

—

Pregnancy examination and test

472

1.30

1.70

1.2

1.3

—

nmol/l

—

Malignant neoplasm of head and neck

340

1.45

1.70

1.6

1.3

—

nmol/l

—

Colorectal cancer, including Hilmo

168

1291

1.22

1.69

1.2

1.3

—

nmol/l

—

All dysplastic lesions of the vulva

219

1.56

1.68

1.2

1.3

—

nmol/l

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

2.21

1.68

1.0

1.5

—

nmol/l

—

Foreign body on external eye

709

1.30

1.68

1.2

1.3

—

nmol/l

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

308

1.47

1.68

1.4

1.3

—

nmol/l

—

Contact with heat and hot substances

227

1.55

1.68

1.2

1.4

—

nmol/l

—

Hypertrophy of (infrapatellar) fat pad

2.54

1.67

1.6

1.4

—

Primary open-angle glaucoma, strict

172

1421

1.21

1.67

1.3

—

nmol/l

—

Other noninfective disorders of lymphatic vessels and lymph nodes

180

1.62

1.67

1.2

—

nmol/l

—

Primary biliary cholangitis, wide definition

1.87

1.67

1.1

1.3

—

nmol/l

—

Acquired stenosis of external ear canal

2.61

1.67

1.3

1.4

—

nmol/l

—

Other specified disorders of muscle

119

1.78

1.67

1.2

1.4

—

nmol/l

—

Malignant neoplasm of tonsil, including Hilmo

2.12

1.66

2.2

1.3

—

nmol/l

—

Malignant neoplasm of renal pelvis

2.85

1.66

1.0

1.2

—

nmol/l

—

Monoplegia

2.05

1.66

1.1

1.4

—

nmol/l

—

Other ulcerative colitis

252

1.52

1.65

1.1

1.4

—

nmol/l

—

Malignant neoplasm of oropharynx, including Hilmo

1.95

1.65

1.9

1.3

—

nmol/l

—

Deep endometriosis

503

1.36

1.65

1.1

1.3

—

nmol/l

—

Right bundle-branch block

142

1.70

1.65

1.1

1.3

—

nmol/l

—

Secondary and unspecified malignant neoplasm of lymph nodes

376

1.42

1.64

1.1

1.3

—

nmol/l

—

Other, unspecified and serous retinal detachments

127

1.75

1.64

1.8

1.3

—

nmol/l

—

Other disorders of binocular vision

2.27

1.64

1.3

—

nmol/l

—

Use of cabergoline

2.27

1.64

1.3

—

nmol/l

—

Intermittent heterotropia

244

1.52

1.64

1.5

1.2

—

nmol/l

—

Injury of intra-abdominal organs

105

1.82

1.63

1.1

1.4

—

nmol/l

—

Benign neoplasm of ovary

130

1050

1.24

1.63

1.4

1.3

—

nmol/l

—

Pediculosis, acariasis and other infestations

261

1.50

1.63

1.1

1.4

—

nmol/l

—

Other or unspecified common variable immunodeficiency

3.67

1.63

1.2

1.3

—

Other sideroblastic anaemias

3.66

1.63

1.0

1.7

—

nmol/l

—

Malignant neoplasm of thymus, including Hilmo

3.65

1.62

1.0

1.6

—

nmol/l

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

3.65

1.62

1.2

—

Failed attempted abortion

2.41

1.62

1.0

1.1

—

Gastrojejunal ulcer

2.41

1.62

1.0

1.4

—

nmol/l

—

Benign neoplasm: Skin of other and unspecified parts of face

505

1.35

1.61

1.2

1.3

—

nmol/l

—

Systemic sclerosis

113

1.79

1.61

1.3

1.2

—

nmol/l

—

Vascular syndromes of brain in cerebrovascular disorders

174

1.62

1.61

1.4

1.3

—

nmol/l

—

Dronedarone medication

113

1.78

1.61

1.2

—

nmol/l

—

Habit and impulse disorders

2.08

1.60

1.5

1.6

—

nmol/l

—

Abnormal findings on diagnostic imaging of breast

1.97

1.60

1.3

1.2

—

nmol/l

—

Personal history of certain other diseases

2.08

1.60

1.2

—

nmol/l

—

Secondary parkinsonism, excluding more controls

2.08

1.60

1.3

1.6

—

Paranoid personality disorder

2.02

1.60

1.2

1.3

—

nmol/l

—

Scabies

198

1.57

1.60

1.1

1.4

—

nmol/l

—

Other and unspecified diseases of spleen

3.07

1.59

1.3

1.5

—

nmol/l

—

Cerebral amyloid angiopathy

2.76

1.59

1.1

1.4

—

nmol/l

—

Benign neoplasm: other/unspecified salivary gland

106

1.81

1.59

1.3

1.2

—

nmol/l

—

Other and unspecified vasculitis limited to skin

1.83

1.58

1.5

1.3

—

nmol/l

—

Superficial injury of hip and thigh

751

1.28

1.58

1.3

—

nmol/l

—

Any death

381

3006

0.88

1.57

1.3

—

nmol/l

—

Sequelae of injuries of lower limb

456

1.37

1.57

1.5

1.3

—

nmol/l

—

Bicuspidal aortic valve syndrome

152

1.66

1.57

1.2

1.4

—

nmol/l

—

Colorectal cancer

149

1176

1.22

1.56

1.3

—

nmol/l

—

Pyothorax

160

1.63

1.56

1.2

1.4

—

nmol/l

—

Acute bronchiolitis

172

1.58

1.56

1.1

1.2

—

nmol/l

—

Malignant neoplasm of head and neck, including Hilmo

431

1.37

1.56

1.5

1.3

—

nmol/l

—

Primary open-angle glaucoma

207

1690

1.18

1.56

1.3

—

nmol/l

—

Other and unspecified disorders of skin and subcutaneous tissue

297

1.46

1.56

1.1

1.3

—

nmol/l

—

Fistulae involving female genital tract

1.94

1.55

2.4

1.2

—

nmol/l

—

Abnormal findings in nipple discharge synovial fluid wound secretions

2.06

1.55

1.3

—

Crowding of teeth, including avohilmo

279

1.43

1.55

1.2

1.3

—

nmol/l

—

Malignant neoplasm, without specification of site

122

1.73

1.55

1.4

1.3

—

nmol/l

—

Contact with lifting and transmission devices, not elsewhere classified

2.05

1.55

1.2

1.3

—

nmol/l

—

Other and unspecified coagulation defects

232

1.52

1.54

1.1

1.3

—

nmol/l

—

Fracture of lumbar spine and pelvis

144

1181

1.22

1.54

1.2

1.3

—

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of thorax

153

1.64

1.53

1.2

1.4

—

nmol/l

—

Hair colour and hair shaft abnormalities

3.41

1.53

1.0

1.1

—

Precocious central puberty

3.38

1.53

3.0

1.3

—

nmol/l

—

Symptoms and signs involving emotional state

115

1.75

1.53

1.1

1.5

—

nmol/l

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

720

1.28

1.52

1.4

1.3

—

nmol/l

—

Explicit bacterial Sepsis, including avohilmo

450

1.36

1.52

1.1

1.3

—

nmol/l

—

Attention to artificial openings

169

1.61

1.52

1.1

1.4

—

nmol/l

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

1.84

1.52

1.9

1.4

—

nmol/l

—

Other disorders of prostate

1.84

1.52

1.1

1.4

—

nmol/l

—

Necrotizing fasciitis

2.91

1.51

1.5

1.4

—

nmol/l

—

Unspecified parasitic disease

2.89

1.51

1.2

1.1

—

nmol/l

—

Inflammatory diseases of the central nervous system

392

1.38

1.50

1.2

1.3

—

nmol/l

—

Exposure to other and unspecified man-made environmental factors

1.96

1.49

1.0

1.3

—

nmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

308

1829

1.14

1.49

1.4

1.2

—

nmol/l

—

Malignant neoplasm of floor of mouth, including Hilmo

2.47

1.49

1.1

1.3

—

Paralytic strabismus

300

1.44

1.49

1.6

1.3

—

nmol/l

—

Benign neoplasm: Scapula and long bones of upper limb

2.46

1.49

1.1

1.4

—

Prepatellar bursitis

186

1.57

1.48

1.3

1.4

—

nmol/l

—

Previous suicide attempt

2.46

1.48

1.0

1.5

—

nmol/l

—

Noise effects on inner ear

139

1.66

1.48

1.2

1.5

—

nmol/l

—

Aphakia

2.45

1.48

1.2

—

nmol/l

—

Primary biliary cholangitis (PBC)

1.82

1.48

1.1

1.3

—

nmol/l

—

Bacterial, viral and other infectious agents

393

1.38

1.48

1.8

1.4

—

nmol/l

—

Other articular cartilage disorders

1.82

1.48

1.2

1.5

—

nmol/l

—

SLE (Finngen)

155

1.62

1.47

1.4

1.3

—

nmol/l

—

Personal history of risk-factors, not elsewhere classified

2.24

1.47

1.0

1.3

—

nmol/l

—

Cicatricial alopecia [scarring hair loss]

2.41

1.47

1.6

1.4

—

nmol/l

—

Benign neoplasm: Short bones of lower limb

2.40

1.46

1.1

1.3

—

nmol/l

—

Pneumonia due to Streptococcus pneumoniae

163

1.60

1.46

1.5

1.3

—

nmol/l

—

Recurrent dislocation and subluxation of joint

301

1.43

1.46

1.1

1.4

—

nmol/l

—

Other benign neoplasm of uterus: Cervix uteri

2.54

1.46

1.6

1.1

—

Disorders of parathyroid gland, other and/or unspecified

2.54

1.46

2.7

1.3

—

nmol/l

—

Pseudomembranous colitis

2.53

1.46

1.7

1.4

—

nmol/l

—

Male infertility

179

1.57

1.46

1.3

1.5

—

nmol/l

—

Synovial hypertrophy, not elsewhere classified

2.53

1.46

1.0

1.7

—

Chondromalacia

117

1.72

1.45

1.2

1.3

—

nmol/l

—

Diseases of spleen

1.89

1.45

1.5

1.3

—

nmol/l

—

Other and unspecified injuries of head

335

1.41

1.45

1.3

1.4

—

nmol/l

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

117

1.72

1.45

1.6

1.3

—

nmol/l

—

Alcohol withdrawal state with delirium

285

1.45

1.4

—

nmol/l

—

Anxious personality disorder

1.89

1.45

1.1

1.4

—

nmol/l

—

Injury of urinary and pelvic organs

1.89

1.45

1.3

—

nmol/l

—

Hypotension due to drugs

2.14

1.45

1.4

1.3

—

nmol/l

—

Asymmetry of jaw

2.14

1.45

1.5

1.3

—

nmol/l

—

Injury of blood vessels at lower leg level

3.19

1.45

1.0

1.7

—

Right side

2.78

1.44

1.2

1.4

—

Carcinoma in situ of colon

125

1.69

1.44

1.5

1.3

—

nmol/l

—

Unspecified parasitic disease, including avohilmo

2.76

1.44

1.2

1.1

—

nmol/l

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

164

1.60

1.44

1.2

1.4

—

nmol/l

—

Systemic sclerosis, icd10

118

1.71

1.42

1.3

—

nmol/l

—

Other and unspecified intracranial injuries

118

1.71

1.41

1.4

1.3

—

nmol/l

—

Migraine without aura, drug-induced

2.20

1.41

1.4

1.2

—

nmol/l

—

Unspecified abortion

251

0.55

1.41

1.1

1.3

—

Other hammer toe(s) (acquired)

116

857

1.23

1.40

1.3

—

nmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

318

1891

1.14

1.40

1.4

1.2

—

nmol/l

—

Other and unspecified primary disorders of muscles

2.45

1.40

1.1

1.2

—

nmol/l

—

Guttate psoriasis

2.10

1.39

1.3

1.2

—

Cardiomyopathy, Hypertrophic obstructive

1.96

1.39

1.2

1.3

—

nmol/l

—

Female infertility, tubal origin

222

1.49

1.38

1.2

1.4

—

nmol/l

—

Pulmonary oedema

2.02

1.38

1.5

1.2

—

nmol/l

—

Abnormal reflex

2.66

1.38

1.2

1.1

—

Ingrowing nail

247

1.46

1.38

1.2

1.3

—

nmol/l

—

Acquired clawhand, clubhand, clawfoot and clubfoot

2.65

1.37

1.0

1.4

—

Chronic tubulo-interstitial nephritis

158

1.59

1.37

1.1

1.3

—

nmol/l

—

Benign neoplasm: Oesophagus

2.22

1.37

1.1

1.3

—

nmol/l

—

Wilms' tumor, including Hilmo

2.65

1.37

2.0

1.6

—

nmol/l

—

Lesion of lateral popliteal nerve

190

1.53

1.37

1.4

1.5

—

nmol/l

—

Burns and corrosions confined to eye and internal organs

104

1.74

1.37

1.2

1.3

—

nmol/l

—

Malignant neoplasm of nasopharynx, including Hilmo

2.99

1.37

1.0

1.6

—

nmol/l

—

Complications of genitourinary prosthetic devices, implants and grafts

112

1.71

1.36

1.3

1.2

—

Other acquired deformities of musculoskeletal system and connective tissue

207

1.51

1.35

1.3

—

nmol/l

—

Lung diseases due to external agents

600

1.29

1.35

1.5

1.3

—

nmol/l

—

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

0.00

1.35

0.0

1.6

—

Brain meningioma

265

1.44

1.34

1.3

—

nmol/l

—

Trichomoniasis, including avohilmo

2.17

1.34

1.4

1.2

—

nmol/l

—

Toxic effect of other and unspecified substances

2.15

1.34

1.3

1.7

—

Haemorrhagic disorder due to circulating anticoagulants

2.15

1.34

1.1

1.3

—

nmol/l

—

Inflammatory disorders of male genital organs, not elsewhere classified

2.15

1.34

1.3

1.6

—

nmol/l

—

Retinal detachments and breaks

233

2026

1.15

1.34

1.3

—

nmol/l

—

Central retinal artery occlusion

1.93

1.34

1.4

—

nmol/l

—

Calcaneal spur

1.99

1.33

1.5

1.3

—

nmol/l

—

Otitis media, unspecified

456

1.32

1.33

1.2

1.3

—

nmol/l

—

Open wound of thorax

2.06

1.33

1.2

1.7

—

nmol/l

—

Brain meningioma, including Hilmo

274

1.43

1.33

1.3

—

nmol/l

—

Other and unspecified injuries of shoulder and upper arm

136

1.63

1.33

1.1

1.3

—

nmol/l

—

Other degenerative diseases of the nervous system

156

955

1.19

1.33

1.4

1.3

—

nmol/l

—

Urethral stricture

208

1.50

1.32

1.4

—

nmol/l

—

Focal brain injury

208

1.49

1.32

1.1

1.4

—

nmol/l

—

Vitreous haemorrhage

497

1.31

1.32

1.3

1.4

—

nmol/l

—

Explicit bacterial Sepsis

436

1.33

1.32

1.1

1.3

—

nmol/l

—

Benign neoplasm: Choroid

325

1.39

1.32

1.3

—

nmol/l

—

Other benign neoplasms of uterus

258

1.44

1.32

1.3

—

nmol/l

—

Dermatitis due to substances taken internally

258

1.44

1.31

1.6

1.3

—

nmol/l

—

Abnormality of white blood cells, not elsewhere classified

2.12

1.31

1.2

—

Other and unspecified disorders of adult personality and behaviour

2.54

1.31

1.2

1.5

—

nmol/l

—

Horner syndrome

2.11

1.31

2.0

1.4

—

Pervasive developmental disorders excl. Autism + Asperger

2.41

1.30

1.0

1.4

—

nmol/l

—

Malignant neoplasm of meninges, including Hilmo

2.84

1.29

1.2

—

Other and unspecified neuropathies

2.83

1.29

1.4

1.6

—

Unspecified transport accident

2.82

1.29

1.2

1.7

—

nmol/l

—

Laparoscopic left hemicolectomy

1.90

1.29

1.2

1.3

—

nmol/l

—

Syndrome of inappropriate secretion of antidiuretic hormone

2.82

1.29

3.6

1.2

—

nmol/l

—

Overexertion and strenuous or repetitive movements

491

1.31

1.28

1.3

—

nmol/l

—

Other and unspecified injuries of abdomen, lower back and pelvis

2.02

1.28

1.0

1.4

—

nmol/l

—

Abscess of Bartholin gland

122

1.65

1.28

1.3

1.2

—

nmol/l

—

Complications associated with artificial fertilization

2.01

1.28

2.7

1.1

—

nmol/l

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

202

1.49

1.27

1.2

1.4

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.06

1.27

1.0

1.3

—

nmol/l

—

Myeloproliferative diseases

405

1.34

1.26

1.3

—

nmol/l

—

Myeloproliferative diseases (CML excluded)

362

1.36

1.26

1.2

1.3

—

nmol/l

—

Pterygium

107

1.69

1.26

1.2

1.3

—

nmol/l

—

Other congenital malformations of skin, including avohilmo

388

1.35

1.26

1.3

—

nmol/l

—

Sequelae of infectious and parasitic diseases, including avohilmo

328

1.38

1.26

1.2

1.4

—

nmol/l

—

Bicipital tendinitis

219

1.47

1.26

1.1

1.3

—

nmol/l

—

Open wound of ankle and foot

475

1.31

1.25

1.3

—

nmol/l

—

Infarction of spleen

2.44

1.25

1.7

1.5

—

nmol/l

—

Open wound of neck

2.25

1.25

1.1

1.4

—

nmol/l

—

Tetraplegia

2.43

1.25

1.2

—

Disorders of brain, other and unspecified

2.25

1.25

1.1

1.3

—

nmol/l

—

Encephalitis

123

1.64

1.24

1.1

1.3

—

nmol/l

—

Certolizumab pegol

1.87

1.24

1.2

1.3

—

nmol/l

—

Other specified and unspecified strabismus

2.02

1.24

1.3

—

Other vitreous opacities

179

1.52

1.24

1.1

1.3

—

nmol/l

—

Systemic lupus erythematosus, unspecified

147

1.58

1.23

1.5

1.3

—

nmol/l

—

Congenital malformations of aortic and mitral valves

171

1.53

1.23

1.2

1.4

—

nmol/l

—

Benign neoplasm: Duodenum

108

1.68

1.23

1.3

1.2

—

nmol/l

—

Personal history of allergy to drugs, medicaments and biological substances

2.06

1.22

1.1

1.2

—

nmol/l

—

Carcinoma in situ of skin, other sites/unspecified

1.98

1.22

1.5

1.2

—

nmol/l

—

Papillary adenocarcinoma of thyroid gland

279

1.41

1.22

1.3

—

nmol/l

—

Idiopathic thrombocytopenic purpura

108

1.68

1.22

1.7

1.3

—

nmol/l

—

Leiomyosarcoma

2.20

1.22

1.3

1.1

—

Congenital varicose veins

2.68

1.22

1.4

1.6

—

nmol/l

—

Lichen sclerosus et atrophicus

699

1.25

1.22

1.2

1.3

—

nmol/l

—

Benign neoplasm: Retina

2.67

1.22

3.8

1.2

—

nmol/l

—

Malignant neoplasm of bladder

212

1.47

1.22

1.3

—

nmol/l

—

Left ventricular outflow tract obstruction, narrow definition

196

1.49

1.22

1.2

1.4

—

nmol/l

—

Total colectomy operation

188

1.50

1.21

1.8

1.4

—

nmol/l

—

Total colectomy

188

1.50

1.21

1.8

1.4

—

nmol/l

—

Amputation of toe

288

1.39

1.21

1.3

—

nmol/l

—

Alopecia areata

124

1.62

1.21

1.2

1.3

—

nmol/l

—

Need for other prophylactic measures

263

1.41

1.21

1.3

—

nmol/l

—

Melanocytic naevi of lower limb, including hip

213

1.46

1.20

1.4

1.3

—

nmol/l

—

Primary_lymphoid and hematopoietic malignant neoplasms

146

1237

1.18

1.20

1.4

1.3

—

nmol/l

—

Enteropathic arthropathies

101

1.70

1.20

1.1

1.4

—

nmol/l

—

Campylobacter enteritis

101

1.69

1.20

1.1

1.3

—

nmol/l

—

Tuberculosis of other organs

1.84

1.20

2.0

1.2

—

nmol/l

—

Chromophobe cell carcinoma of kidney

2.35

1.19

1.2

—

nmol/l

—

Benign neoplasm: Ill-defined sites within the digestive system

2.34

1.19

3.3

1.1

—

Traction detachment of retina

2.33

1.19

1.5

—

Other injuries of spine and trunk, level unspecified

2.13

1.19

1.4

1.3

—

nmol/l

—

Ascites

315

1.37

1.18

1.5

1.4

—

nmol/l

—

Struck by thrown, projected or falling objec

214

1.45

1.18

1.1

1.4

—

nmol/l

—

Contact with nonpowered hand tool

173

1.51

1.18

1.3

1.4

—

nmol/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

358

1.34

1.18

1.1

1.3

—

nmol/l

—

Fourth [trochlear] nerve palsy

1.72

1.18

1.1

1.3

—

nmol/l

—

Non-Hodgkin lymphoma, all, including Hilmo

613

1.26

1.18

1.2

1.3

—

nmol/l

—

Other and unspecified psoriasis

307

1.37

1.17

1.5

1.4

—

nmol/l

—

Nummular dermatitis

402

1.32

1.17

1.4

1.3

—

nmol/l

—

Congenital malformations of great arteries

1.88

1.17

1.0

1.5

—

nmol/l

—

Nystagmus and other irregular eye movements

2.02

1.17

1.2

1.3

—

nmol/l

—

Trichomoniasis

2.08

1.16

1.4

1.2

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

2.54

1.16

1.4

1.3

—

nmol/l

—

Gout due to impairment of renal function

2.07

1.16

1.1

1.3

—

nmol/l

—

Other and unspecified medical devices associated with adverse incidents

2.54

1.16

1.0

1.2

—

nmol/l

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

182

1.49

1.16

1.3

1.4

—

nmol/l

—

Hyperprolactinaemia, drug-induced

2.54

1.16

1.2

—

nmol/l

—

Burn and corrosion of trunk

110

1.65

1.15

1.1

1.3

—

nmol/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

2.53

1.15

1.0

1.6

—

Unspecified human immunodeficiency virus [HIV] disease

0.00

1.15

0.0

1.7

—

Dermatitis herpetiformis

1.82

1.15

1.4

1.3

—

nmol/l

—

Benign neoplasm of eye and adnexa

553

1.27

1.15

1.5

1.3

—

nmol/l

—

Contact with other hot fluids

126

1.60

1.15

1.2

1.3

—

nmol/l

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

465

1.29

1.14

1.3

—

nmol/l

—

Recurrent and persistent haematuria

2.36

1.13

1.0

1.2

—

nmol/l

—

Dermatopolymyositis (FG)

1.91

1.12

1.0

1.3

—

nmol/l

—

Kyphosis

2.02

1.12

1.1

—

nmol/l

—

Female infertility, cervical, vaginal, other or unspecified origin

165

905

1.17

1.12

1.3

—

nmol/l

—

Other prurigo

1.98

1.12

1.0

1.4

—

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

151

1.53

1.12

1.4

1.3

—

nmol/l

—

All dysplastic lesions of the vagina

135

1.57

1.12

1.0

1.3

—

nmol/l

—

Sulfasalazine

183

1590

1.15

1.12

1.2

1.3

—

nmol/l

—

Other maltreatment syndromes

127

1.58

1.11

1.2

1.4

—

nmol/l

—

Benign neoplasm of other and unspecified female genital organs

234

1.42

1.11

1.6

1.3

—

nmol/l

—

Congenital deformities of feet

1.68

1.10

1.3

—

nmol/l

—

Ulcerative proctitis

268

1.39

1.10

1.2

1.4

—

nmol/l

—

Other respiratory diseases principally affecting the interstitium

103

854

1.21

1.10

1.5

1.3

—

nmol/l

—

Malignant neoplasm of oesophagus, including Hilmo

137

0.51

1.10

1.1

1.3

—

nmol/l

—

Injury of nerves and spinal cord at thorax level

2.42

1.09

1.2

1.5

—

Renal agenesis and other reduction defects of kidney, including avohilmo

2.41

1.09

1.6

—

nmol/l

—

Cholangitis (primary sclerosing, PSC)

260

1.39

1.09

1.2

1.3

—

nmol/l

—

Open wound of shoulder and upper arm

1.74

1.09

2.4

1.3

—

nmol/l

—

Liposarcoma, including Hilmo

1.97

1.09

1.1

1.3

—

Benign neoplasm of other and unspecified intrathoracic organs

1.97

1.09

2.3

1.4

—

nmol/l

—

Lesion of sciatic nerve

144

1.53

1.08

1.1

1.3

—

nmol/l

—

Alcohol abuse, main dg, excluding more controls

647

1.24

1.08

1.3

1.4

—

nmol/l

—

CR(E)ST syndrome

1.77

1.07

1.4

1.3

—

nmol/l

—

severe traumatic brain injury, does not include concussion

129

1095

1.18

1.07

1.3

—

nmol/l

—

Benign neoplasm: Pharynx, unspecified

2.15

1.06

1.0

1.6

—

nmol/l

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

113

1.60

1.06

1.1

1.4

—

nmol/l

—

Other (seronegative) rheumatoid arthritis, wide

122

1032

1.18

1.06

1.2

1.3

—

nmol/l

—

Lesion of radial nerve

145

1.52

1.06

1.0

1.5

—

nmol/l

—

Superficial injuries involving multiple body regions

113

1.60

1.06

1.1

1.3

—

nmol/l

—

Assault by other specified means

2.14

1.06

1.0

1.6

—

Oligomenorrhoea

137

1.54

1.06

1.2

—

nmol/l

—

Use of biperiden

241

0.62

1.05

1.5

1.4

—

nmol/l

—

Schizoid personality disorder

1.81

1.05

1.4

1.6

—

nmol/l

—

Congenital malformations of heart and great arteries

578

1.24

1.05

1.6

1.3

—

nmol/l

—

Malignant neoplasm of brain, including Hilmo

220

1.42

1.05

1.3

1.2

—

nmol/l

—

Artificial opening status

237

1.40

1.04

1.2

1.3

—

nmol/l

—

Exfoliative dermatitis

1.98

1.04

2.1

1.3

—

nmol/l

—

Disorders of phosphorus metabolism and phosphatases

2.31

1.04

1.2

1.5

—

Disorders of purine and pyrimidine metabolism

2.30

1.04

1.4

1.3

—

nmol/l

—

Disorders of puberty, all

1.97

1.04

1.1

1.4

—

nmol/l

—

Epiphora

1.64

1.03

1.1

1.3

—

Osteonecrosis due to drugs

1.85

1.03

1.4

—

nmol/l

—

Malignant neoplasm of corpus uteri, including Hilmo

544

1.25

1.03

1.3

1.2

—

nmol/l

—

Car occupant injured in noncollision transport accident

146

1.51

1.03

1.2

1.4

—

nmol/l

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

138

1.53

1.03

1.2

1.4

—

nmol/l

—

Habitual aborter

1.84

1.03

1.2

—

nmol/l

—

Other congenital malformations of circulatory system

114

1.59

1.03

1.3

—

nmol/l

—

Lung cancer and mesothelioma

106

752

1.20

1.03

1.2

1.3

—

nmol/l

—

Leiomyosarcoma, including Hilmo

1.94

1.03

1.2

—

Additional codes for the location of defect, injury or illness

272

1.37

1.03

1.1

1.3

—

nmol/l

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

1.93

1.02

1.2

1.4

—

nmol/l

—

Fasciculation

1.93

1.02

1.1

1.3

—

nmol/l

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

1.93

1.02

1.9

1.3

—

nmol/l

—

Sequelae of tuberculosis, including avohilmo

1.93

1.02

1.2

1.4

—

nmol/l

—

Mental retardation, excluding more controls

118

1.56

1.01

1.2

1.5

—

nmol/l

—

Sequelae of other accidents

1.89

1.00

1.1

1.3

—

nmol/l

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

2.02

1.00

4.1

1.3

—

Psoriasis vulgaris

117

992

1.18

1.00

1.3

—

nmol/l

—

Unspecified event, undetermined intent

1.63

1.00

1.3

1.4

—

nmol/l

—

Melanocytic naevi of other and unspecified parts of face

282

1.35

1.00

1.3

—

nmol/l

—

Event of undetermined intent

282

1.35

1.00

1.3

1.4

—

nmol/l

—

Dissection of aorta

1.62

1.00

1.5

1.3

—

nmol/l

—

SLE, strict definition

164

1.47

0.99

1.5

1.3

—

nmol/l

—

SLE, ICD10

164

1.47

0.99

1.5

1.3

—

nmol/l

—

!Aliquae complicationes praecoces traumatis

189

1.43

0.99

1.4

—

nmol/l

—

Early complications of trauma

189

1.43

0.99

1.4

—

nmol/l

—

Status post-ami

127

821

1.17

0.99

1.3

—

nmol/l

—

Other specified/unspecified deforming dorsopathies

1.82

0.99

1.1

1.5

—

nmol/l

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

107

1.59

0.98

1.2

1.4

—

nmol/l

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

2.20

0.98

1.0

1.2

—

nmol/l

—

Dermatopolymyositis, unspecified

2.20

0.98

1.0

1.1

—

Unspecified protein-energy malnutrition

2.20

0.98

1.2

1.6

—

Whooping cough

2.20

0.98

1.0

1.4

—

Alzheimer’s disease (Early onset)

158

0.57

0.98

1.4

1.2

—

nmol/l

—

Scissor bite

1.68

0.98

1.1

1.3

—

nmol/l

—

Coarctation of the aorta

1.96

0.97

1.0

1.6

—

nmol/l

—

Pleural plaque with presence of asbestos

232

1.38

0.97

1.2

1.3

—

nmol/l

—

therapeutic use

132

1.52

0.97

1.1

1.3

—

nmol/l

—

Other specified/unspecified necrotizing vasculopathies

1.87

0.97

1.3

—

nmol/l

—

Traumatic ischaemia of muscle

1.87

0.97

1.6

1.3

—

nmol/l

—

Tic and related disorders

1.95

0.97

1.0

1.4

—

nmol/l

—

Mixed specific developmental disorders

1.81

0.97

1.4

1.2

—

nmol/l

—

Secondary right heart disease

157

1.47

0.96

1.3

—

nmol/l

—

Sequelae of infectious and parasitic diseases

319

1.32

0.96

1.1

1.4

—

nmol/l

—

Microscopic polyangiitis

0.00

0.96

0.0

1.2

—

Scar conditions and fibrosis of skin

199

1.41

0.95

1.2

1.3

—

nmol/l

—

Meningococcal infection

0.00

0.95

0.0

1.4

—

Meningococcal infection, including avohilmo

0.00

0.95

0.0

1.4

—

Abscess of anal and rectal regions

372

1.29

0.95

1.2

1.3

—

nmol/l

—

Ulcerative rectosigmoiditis

381

1.29

0.95

1.1

1.4

—

nmol/l

—

Measles

1.78

0.95

1.2

1.5

—

nmol/l

—

Measles, including avohilmo

1.78

0.95

1.2

1.5

—

nmol/l

—

Dermatopolymyositis

1.79

0.94

1.0

1.3

—

nmol/l

—

Chorioretinal inflammation

125

1.53

0.94

1.1

1.4

—

nmol/l

—

Emotional disorders starting during childhood or adolecense, excluding more controls

113

1.55

0.94

1.4

1.3

—

nmol/l

—

Other misadventures during surgical and medical care

1.62

0.94

1.3

1.4

—

nmol/l

—

Congenital malformations of spine and bony thorax, including avohilmo

2.25

0.94

1.2

1.5

—

nmol/l

—

Malignant neoplasm of stomach, including Hilmo

217

1.39

0.93

1.4

—

nmol/l

—

Psoriasis (vulgaris), strict definition

150

1.47

0.93

1.1

1.4

—

nmol/l

—

Toxic effect of contact with venomous animals

192

1.41

0.92

1.1

1.3

—

nmol/l

—

Hereditary retinal dystrophy

1.83

0.92

1.0

1.3

—

nmol/l

—

Lower leg

2.17

0.92

1.0

1.5

—

nmol/l

—

Other and unspecified disease of Bartholin gland

134

1.50

0.92

1.2

—

nmol/l

—

Other osteochondropathies

304

1.32

0.92

1.1

1.4

—

nmol/l

—

Other and unspecified disorders of psychological development

2.17

0.92

1.0

1.1

—

nmol/l

—

Epidural haemorrhage

2.16

0.92

2.8

1.3

—

nmol/l

—

Benign lipomatous neoplasm of other sites/unspecified

410

1.27

0.91

1.4

—

nmol/l

—

Benign neoplasm: Cranial nerves

126

1.52

0.91

1.9

1.3

—

nmol/l

—

Personal history of malignant neoplasm

464

0.75

0.91

1.1

1.3

—

nmol/l

—

Use of disulfiram, acamprosate or naltrexone

419

1.27

0.91

1.2

1.4

—

nmol/l

—

Cutaneous lupus erythematosus

118

1.54

0.91

1.4

1.3

—

nmol/l

—

Systemic lupus erythematosus

176

1.43

0.91

1.4

1.3

—

nmol/l

—

Other superficial mycoses

1.61

0.91

1.9

1.3

—

nmol/l

—

Follicular lymphoma, hilmo

176

1.43

0.91

1.1

1.3

—

nmol/l

—

Dilated cardiomyopathy

509

1.24

0.90

1.4

1.3

—

nmol/l

—

Infection due to other mycobacteria

1.76

0.90

1.3

—

nmol/l

—

Injury of cranial nerves

2.10

0.90

3.3

1.5

—

nmol/l

—

Complications following abortion and ectopic and molar pregnancy

185

1.41

0.89

1.1

1.4

—

nmol/l

—

Unspecified acute lower respiratory infection

746

1.20

0.89

1.4

1.3

—

nmol/l

—

Primary coxarthrosis, bilateral

187

1659

1.13

0.89

1.3

—

nmol/l

—

Malignant neoplasm of oesophagus

104

0.48

0.89

1.2

1.3

—

nmol/l

—

Palindromic rheumatism

1.92

0.89

1.3

1.5

—

Contact with venomous snakes and lizards

1.92

0.89

1.0

1.4

—

nmol/l

—

Disorders of porphyrin and bilirubin metabolism

1.92

0.89

1.5

1.4

—

nmol/l

—

Type 1 diabetes, definitions combined

393

1.27

0.88

1.7

1.2

—

nmol/l

—

Maternal care for cervical incompetence

194

1.40

0.88

1.1

1.3

—

nmol/l

—

Von Willebrand disease

1.80

0.88

1.4

1.2

—

nmol/l

—

Circumscribed brain atrophy

1.66

0.88

1.2

1.3

—

nmol/l

—

Postzoster neuralgia

1.80

0.88

1.1

1.3

—

nmol/l

—

Other benign neoplasm of uterus: Corpus uteri

1.88

0.88

1.0

1.3

—

nmol/l

—

Injuries involving multiple body regions

169

1.43

0.87

1.1

1.3

—

nmol/l

—

Liposarcoma

2.02

0.87

1.2

1.4

—

Lymphoid leukaemia

220

1.37

0.87

1.5

1.3

—

nmol/l

—

Other surgical follow-up care

144

1.46

0.87

1.0

1.3

—

nmol/l

—

Melanoma in situ of upper limb, including shoulder

2.02

0.87

1.2

—

Polymyositis

2.02

0.87

1.0

1.3

—

nmol/l

—

Bullous keratopathy

2.02

0.87

2.5

1.3

—

nmol/l

—

Other congenital malformations of intestine

2.02

0.87

1.8

1.3

—

nmol/l

—

Sequelae of poliomyelitis, including avohilmo

2.02

0.87

1.2

1.4

—

Malignant neoplasm of breast, HER-positive

189

1581

0.89

0.87

1.4

1.2

—

nmol/l

—

Disorders of eyelid in diseases classified elsewhere

136

1.48

0.86

1.6

1.3

—

nmol/l

—

Postpartum haemorrhage due to retained placenta

605

0.79

0.86

1.2

—

nmol/l

—

Ovarian hyperstimulation (induction)

1.73

0.86

2.7

1.3

—

nmol/l

—

Viral conjunctivitis, including avohilmo

178

1.41

0.86

1.2

1.4

—

nmol/l

—

Visual impairment including blindness (binocular or monocular)

290

1.31

0.86

1.4

1.3

—

nmol/l

—

Hypermetropia

316

1.30

0.86

1.3

—

nmol/l

—

Other congenital malformations of the digestive system, including avohilmo

202

1.38

0.86

1.6

1.2

—

nmol/l

—

Perichondritis of external ear

1.68

0.85

1.2

1.3

—

nmol/l

—

Foreign body in alimentary tract

221

1.36

0.85

1.4

1.3

—

nmol/l

—

Parapsoriasis

1.68

0.85

1.3

1.4

—

nmol/l

—

Separation of retinal layers (serosa)

187

1.40

0.85

1.3

1.4

—

nmol/l

—

Hepatocellular carcinoma, including Hilmo

112

1.53

0.85

1.2

1.3

—

nmol/l

—

Endometriosis of fallopian tube

1.95

0.85

1.0

1.3

—

nmol/l

—

Malignant neoplasm of breast, ER-positive, including Hilmo

190

1584

0.89

0.85

1.4

1.2

—

nmol/l

—

Malignant immunoproliferative diseases

1.95

0.84

1.0

1.4

—

nmol/l

—

Other specified and unspecified disorders of conjunctiva

1.79

0.84

1.0

1.4

—

nmol/l

—

Use of rotigotine

1.79

0.84

1.4

—

nmol/l

—

Other specific arthropathies, wide

1.60

0.84

1.2

1.4

—

Non-small cell lung cancer, adenocarcinoma

265

1.32

0.84

1.1

1.3

—

nmol/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

196

1.38

0.84

1.3

1.4

—

nmol/l

—

Injury of muscle and tendon at lower leg level

752

1.19

0.83

1.2

1.4

—

nmol/l

—

Type 1 diabetes, strict (exclude DM2)

388

1.26

0.83

1.7

1.2

—

nmol/l

—

Degenerative macular diseases

579

1.21

0.83

1.2

1.3

—

nmol/l

—

Organic, including symptomatic, mental disorders

294

2263

0.91

0.82

1.3

—

nmol/l

—

Sequelae of tuberculosis

1.75

0.82

1.3

1.4

—

nmol/l

—

Sexual dysfunction

1.70

0.82

1.0

1.5

—

nmol/l

—

Other ill-defined and unspecified causes of mortality

354

1.27

0.82

1.9

1.3

—

nmol/l

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

1.70

0.82

1.2

1.3

—

nmol/l

—

Benign neoplasm: Bone and articular cartilage, unspecified

1.89

0.82

1.2

1.4

—

nmol/l

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.62

0.81

2.3

1.2

—

nmol/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

130

1.47

0.81

1.5

1.4

—

nmol/l

—

Respiratory and cardiovascular disorders specific to the perinatal period

1.71

0.80

1.0

1.1

—

nmol/l

—

Tubulo-interstitial nephritis, not specified as acute or chronic

276

1.31

0.80

1.1

1.3

—

nmol/l

—

Assault by blunt object

1.74

0.80

1.4

1.6

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

1.74

0.80

1.5

1.6

—

nmol/l

—

Divergent concomitant strabismus

340

0.73

0.80

1.2

1.3

—

nmol/l

—

Malignant neoplasm of anus and anal canal

0.00

0.79

0.0

1.5

—

Other encephalitis

114

1.50

0.79

1.1

1.2

—

nmol/l

—

Conductive hearing loss, unspecified

374

1.26

0.79

1.2

1.4

—

nmol/l

—

Cleft lip and cleft lip and palate

0.00

0.79

0.0

1.5

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

0.79

0.0

1.8

—

Typhoid and paratyphoid fevers, including avohilmo

0.00

0.79

0.0

1.5

—

Congenital malformations of trachea and bronchus

1.83

0.79

1.2

—

nmol/l

—

Inhalation and ingestion of food causing obstruction of respiratory tract

1.83

0.79

1.2

—

nmol/l

—

Acquired absence of limb

1.83

0.79

1.0

1.2

—

nmol/l

—

Behavioural disorders, excluding more controls

1.73

0.79

1.3

1.7

—

nmol/l

—

Unspecified maternal hypertension

1.68

0.79

1.0

1.2

—

nmol/l

—

Colitis, primary sclerosing

1.68

0.79

1.1

1.3

—

nmol/l

—

Contact with sharp glass

156

1.42

0.79

1.1

1.3

—

nmol/l

—

Lung transplant status

0.00

0.79

0.0

1.5

—

Lung transplantation

0.00

0.79

0.0

1.5

—

Lack of expected normal physiological development

1.67

0.78

1.1

—

nmol/l

—

Other noninflammatory disorders of cervix uteri

251

1.32

0.78

1.2

—

nmol/l

—

Mixed conductive and sensorineural hearing loss

574

1.20

0.78

1.3

—

nmol/l

—

Nail disorders

421

1.24

0.77

1.2

1.3

—

nmol/l

—

Other pulmonary heart/vessel disease

174

1.38

0.76

1.3

—

nmol/l

—

Tarsal tunnel syndrome

1.78

0.76

1.0

1.2

—

Chronic myeloproliferative disease

1.71

0.76

1.2

1.3

—

nmol/l

—

Shoulder region

1.71

0.76

1.0

1.3

—

nmol/l

—

Muscle strain

132

1.45

0.76

1.1

1.3

—

nmol/l

—

Contusion of ankle

183

1.37

0.76

1.3

1.4

—

nmol/l

—

Chronic Coagulation defects

1.52

0.76

1.3

1.2

—

nmol/l

—

Mental retardation

131

1.44

0.75

1.2

1.4

—

nmol/l

—

Short Achilles tendon (acquired)

124

1.46

0.75

1.1

1.3

—

Astigmatism

270

1.30

0.75

1.1

1.3

—

nmol/l

—

Injury of nerves and spinal cord at neck level

1.57

0.75

1.3

—

nmol/l

—

Tuberculosis of other organs, strict

1.57

0.75

2.0

1.2

—

nmol/l

—

Congenital malformations of the respiratory system, including avohilmo

1.61

0.75

1.3

—

nmol/l

—

Malignant neoplasm of stomach

192

1.36

0.75

1.4

1.3

—

nmol/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

253

1.31

0.75

1.3

1.4

—

nmol/l

—

Polyarteritis nodosa and related conditions

1.68

0.75

1.3

1.4

—

nmol/l

—

Contact with other hot metals

1.68

0.74

1.3

1.4

—

nmol/l

—

Other and unspecified haemorrhagic conditions

1.68

0.74

1.1

1.3

—

Testicular hypofunction

116

1.47

0.74

1.2

—

nmol/l

—

Other interstitial pulmonary diseases

716

1.18

0.74

1.5

1.3

—

nmol/l

—

Congenital malformations of gallbladder, bile ducts and liver

1.86

0.74

1.6

1.4

—

nmol/l

—

Other bursitis of knee

1.65

0.73

1.2

1.5

—

nmol/l

—

Generalized epilepsy

167

1.38

0.73

1.2

1.3

—

nmol/l

—

Other specified and unspecified disorders of eye and adnexa

150

1.41

0.73

1.2

1.3

—

nmol/l

—

Malignant neoplasm of gallbladder

2.03

0.73

1.4

—

nmol/l

—

Cardiomyopathy in other diseases

2.02

0.73

1.2

—

Acute lymphocytic leukaemia

2.02

0.73

1.2

1.5

—

nmol/l

—

Acute lymphocytic leukaemia, helper endpoint

2.02

0.73

1.2

1.5

—

nmol/l

—

Acute lymphocytic leukaemia, including Hilmo

2.02

0.73

1.2

1.5

—

nmol/l

—

Neuroendocrine tumor and carcinoma of lung

1.81

0.73

1.7

1.3

—

Short stature, not elsewhere classified

1.81

0.73

1.3

1.2

—

nmol/l

—

Tic disorders

1.80

0.72

1.0

1.3

—

nmol/l

—

Cholesteatoma of middle ear

202

1.34

0.72

1.4

1.3

—

nmol/l

—

Other demyelinating diseases of the central nervous system

159

1.39

0.72

1.6

1.4

—

nmol/l

—

Exposure to other and unspecified animate mechanical forces

142

1.41

0.72

1.1

1.3

—

nmol/l

—

Complications following infusion, transfusion and therapeutic injection

1.68

0.72

1.2

—

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

1.68

0.72

1.0

1.3

—

Other lack of coordination

1.68

0.72

1.0

1.4

—

nmol/l

—

Contact with machinery

479

1.21

0.72

1.2

1.3

—

nmol/l

—

Interstitial lung disease

718

1.17

0.72

1.5

1.3

—

nmol/l

—

Interstitial lung disease endpoints

718

1.17

0.72

1.5

1.3

—

nmol/l

—

Postpartum haemorrhage due to anatomy

468

0.79

0.72

2.0

1.2

—

nmol/l

—

Specific development disorders of speech and language

203

1.33

0.72

1.2

—

nmol/l

—

Tuberculosis of other organs, strict, including avohilmo

1.56

0.72

2.0

1.2

—

nmol/l

—

Graves ophthalmopathy

117

1.46

0.72

1.1

1.4

—

nmol/l

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.63

0.72

1.3

—

nmol/l

—

Allergic purpura

117

1.46

0.72

1.3

—

nmol/l

—

Malignant neoplasm of liver and intrahepatic bile ducts

117

1.46

0.72

1.3

—

nmol/l

—

LSIL lesion of the vulva

151

1.40

0.71

1.1

1.3

—

nmol/l

—

Macular cyst

134

1.42

0.71

1.1

1.3

—

nmol/l

—

Dependence on enabling machines and devices, not elsewhere classified

1.75

0.71

1.1

1.3

—

nmol/l

—

Malignant neoplasm of floor of mouth

1.95

0.71

1.2

1.4

—

Disorders of acoustic nerve

109

1.48

0.71

1.9

1.3

—

nmol/l

—

Malignant neoplasm of base of tongue

1.94

0.71

1.2

1.4

—

Other and unspecified vaccines and biological substances

1.94

0.71

1.2

—

Valgus deformity, not elsewhere classified

1.94

0.71

1.0

1.5

—

nmol/l

—

Other and unspecified injuries of forearm

1.94

0.71

1.0

1.5

—

nmol/l

—

Blindness, monocular

1.72

0.70

1.3

—

Other injuries of lower limb, level unspecified

1.72

0.70

1.7

1.2

—

nmol/l

—

Adult respiratory distress syndrome

1.72

0.70

1.3

—

nmol/l

—

Malignant neoplasm of eye, brain and central nervous system

195

1.34

0.69

1.4

1.3

—

nmol/l

—

Parkinson's disease, including avohilmo

749

1.16

0.69

1.4

1.3

—

nmol/l

—

Pneumonia due to other infectious organisms, not elsewhere classified

135

1.41

0.69

1.1

1.4

—

nmol/l

—

Reactive arthropathies, FINNGEN

319

1.26

0.69

1.2

1.4

—

nmol/l

—

LeFortI or BSSO operation

178

1.35

0.69

1.4

—

nmol/l

—

Sequelae of poliomyelitis

1.87

0.68

1.0

1.4

—

Leukaemia of unspecified cell type

1.86

0.68

1.0

1.4

—

Alcohol induced polyneuropathy

1.86

0.68

1.4

1.3

—

nmol/l

—

1.68

0.68

1.3

1.4

—

nmol/l

—

Wegener granulomatosis

1.53

0.68

1.3

—

nmol/l

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.53

0.68

1.6

1.5

—

nmol/l

—

Oral lichen planus and hypothyroidism or thyroxine medication

102

1.48

0.68

1.2

—

nmol/l

—

Isolated patent ductus arteriosus

1.84

0.68

1.0

1.2

—

nmol/l

—

Malignant neoplasm of parotid gland, including Hilmo

1.64

0.67

2.1

1.3

—

nmol/l

—

Alcoholic gastritis

1.64

0.67

1.1

—

Disorders of synovium and tendon in diseases classified elsewhere

1.50

0.67

1.0

1.4

—

nmol/l

—

Presbycusis

550

1.19

0.67

1.3

—

nmol/l

—

Disorders of speech understanding and production

150

1.38

0.67

1.2

—

nmol/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

276

1.27

0.67

1.2

1.3

—

nmol/l

—

Transient synovitis

1.80

0.66

1.2

1.4

—

Seminoma of testis, including Hilmo

1.80

0.66

1.2

1.6

—

nmol/l

—

Amputation of foot

1.52

0.66

1.4

1.2

—

nmol/l

—

Bullous disorders

241

1.29

0.66

1.3

1.2

—

nmol/l

—

Malignant neoplasm of larynx, including Hilmo

1.58

0.65

1.2

—

nmol/l

—

Tic and related disorders

1.60

0.65

1.0

1.2

—

nmol/l

—

Carcinoma in situ of skin of ear and external auricular canal

1.60

0.65

1.3

1.1

—

nmol/l

—

Torticollis

1.60

0.65

1.3

1.5

—

nmol/l

—

Palmar fascial fibromatosis [Dupuytren]

642

1.17

0.65

1.2

1.4

—

nmol/l

—

Streptococcal septicaemia

385

1.22

0.65

1.1

1.3

—

nmol/l

—

Viral hepatitis

331

1.24

0.65

1.4

—

nmol/l

—

Colon adenocarcinoma

569

1.18

0.64

1.3

—

nmol/l

—

Carcinoma in situ of skin

395

1.22

0.64

1.1

1.3

—

nmol/l

—

Drug-induced tremor

1.74

0.64

1.0

1.4

—

Malignant neoplasm of gallbladder, including Hilmo

1.74

0.64

1.4

—

nmol/l

—

Other congenital malformations of female genitalia

1.73

0.64

1.4

1.2

—

nmol/l

—

Mesial bite

1.73

0.64

1.4

1.2

—

Alcoholic liver disease

459

1.20

0.64

1.6

1.3

—

nmol/l

—

Antenatal screening

107

681

0.88

0.64

1.2

1.3

—

nmol/l

—

Other deformities of toe(s)

172

1.34

0.64

1.2

1.4

—

nmol/l

—

ILD, hospital admissions

709

1.16

0.63

1.5

1.4

—

nmol/l

—

Amputation of thigh

1.50

0.63

1.0

1.2

—

nmol/l

—

Malignant neoplasm of rectosigmoid junction

1.53

0.63

1.0

1.3

—

nmol/l

—

Ill-defined and unknown causes of mortality

396

1.21

0.63

1.8

1.3

—

nmol/l

—

Viral hepatitis, including avohilmo

351

1.23

0.62

1.4

—

nmol/l

—

Non-Hodgkin lymphoma, all

164

1.35

0.62

1.1

1.3

—

nmol/l

—

Other viral hepatitis

270

1.26

0.62

1.4

—

nmol/l

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

510

1.18

0.62

1.5

1.3

—

nmol/l

—

Other abnormalities of plasma proteins

1.60

0.62

1.3

—

nmol/l

—

Other and unspecified injuries of wrist and hand

173

1.33

0.62

1.3

—

nmol/l

—

1.68

0.61

1.0

1.1

—

nmol/l

—

Dacryoadenitis

1.68

0.61

2.2

1.4

—

Other bursitis of elbow

1.68

0.61

1.0

1.4

—

nmol/l

—

Crystalline deposits in vitreous body

1.68

0.61

1.0

1.5

—

Benign neoplasm: Rectum/anal canal icd-9

1.68

0.61

1.0

1.2

—

nmol/l

—

Other bursitis, not elsewhere classified

1.68

0.61

1.4

1.1

—

nmol/l

—

Open bite that required surgery (Lefort1 or BSSO)

1.68

0.61

1.2

1.1

—

Essential (haemorrhagic) thrombocythaemia

182

1.32

0.61

1.3

—

nmol/l

—

Parkinson's disease

721

1.15

0.61

1.5

1.3

—

nmol/l

—

Parkinson's disease, strict definition

656

1.16

0.61

1.4

1.3

—

nmol/l

—

HSIL lesion of the vulva

1.49

0.61

1.2

1.3

—

nmol/l

—

Injury of other and unspecified intrathoracic organs

262

1.26

0.61

1.5

1.4

—

nmol/l

—

Acute nasopharyngitis (common cold)

577

1.17

0.61

1.3

—

nmol/l

—

Hordeolum and other deep inflammation of eyelid

280

1.25

0.61

1.1

1.4

—

nmol/l

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

280

1.25

0.61

1.1

1.3

—

nmol/l

—

Malignant neoplasm of accessory sinuses, including Hilmo

0.00

0.60

0.0

1.6

—

Ankylosing spondylitis, ICD10

407

1.21

0.60

1.3

—

nmol/l

—

Use of levodopa decarboxylase inhibitor

647

1.16

0.60

1.5

1.3

—

nmol/l

—

Malignant neoplasm of corpus uteri

499

1.19

0.60

1.3

—

nmol/l

—

Rubella [German measles]

140

0.64

0.60

1.1

1.4

—

Other acute skin changes due to ultraviolet radiation

139

1.37

0.60

1.3

1.2

—

nmol/l

—

Ectropion of eyelid

139

1.37

0.60

1.4

1.2

—

nmol/l

—

Use of entacapone

0.00

0.60

0.0

1.1

—

Benign neoplasm: Tongue

122

1.40

0.60

1.1

1.3

—

nmol/l

—

Pedestrian injured in collision with pedal cycle

122

1.40

0.60

1.0

1.3

—

nmol/l

—

Accidental poisoning by and exposure to other gases and vapours

0.00

0.59

0.0

1.5

—

Crushed, pushed or stepped on by crowd or human stampede

335

1.23

0.59

1.0

1.3

—

nmol/l

—

Burn and corrosion, body region unspecified

0.00

0.59

0.0

1.2

—

Benign neoplasm: Orbit, unspecified

0.00

0.59

0.0

1.5

—

Non-seminoma of testis, including Hilmo

0.00

0.59

0.0

1.4

—

Tuberculosis, IBD comorbidity

263

1.26

0.59

1.5

1.3

—

nmol/l

—

Infection due to other mycobacteria, including avohilmo

1.54

0.59

1.3

—

nmol/l

—

Other salmonella infections

157

1.34

0.59

1.5

1.4

—

nmol/l

—

Mental retardation, wide definition

147

1.35

0.59

1.2

1.3

—

nmol/l

—

Crushing injury of wrist and hand

1.57

0.59

1.1

1.4

—

nmol/l

—

Optic atrophy

1.57

0.59

1.4

1.3

—

nmol/l

—

Mucinous and mucinous cystic tumor

0.00

0.58

0.0

1.3

—

Malignant neoplasm of larynx

1.52

0.58

1.1

1.2

—

nmol/l

—

Cutis laxa senilis

1.73

0.58

1.0

1.2

—

Melanocytic naevi of lip

1.73

0.58

1.0

1.3

—

nmol/l

—

Carcinoma in situ of vulva

1.73

0.58

1.3

1.2

—

nmol/l

—

Drug-induced obesity

1.73

0.58

1.2

—

Other bacterial agents as the cause of diseases classified to other chapters

1.73

0.58

2.8

1.4

—

Fibrosis and cirrhosis of liver

373

1.21

0.58

1.2

1.3

—

nmol/l

—

Benign neoplasm: Skin of lip

1.49

0.57

1.4

—

nmol/l

—

Disorders in reading

1.49

0.57

1.6

1.4

—

nmol/l

—

Malignant neoplasm of ovary

275

0.76

0.57

1.8

1.3

—

nmol/l

—

Osteomalacia

1.68

0.57

1.2

1.6

—

Calcific tendinitis

1.68

0.57

1.2

1.3

—

nmol/l

—

Supervision of normal pregnancy

102

657

0.88

0.56

1.1

1.3

—

nmol/l

—

Benign neoplasm of major salivary glands

475

1.18

0.56

1.2

1.3

—

nmol/l

—

Other renal tubulo-interstitial diseases

1.43

0.56

1.1

1.3

—

nmol/l

—

Erythema nodosum

141

1.35

0.56

1.3

1.4

—

nmol/l

—

Conduct disorder

1.51

0.56

1.3

1.5

—

nmol/l

—

Coxarthrosis, primary, with hip surgery

303

2625

1.07

0.56

1.3

—

nmol/l

—

Mandibular prognathia

1.46

0.56

1.5

1.3

—

nmol/l

—

Carcinoma in situ of other and unspecified digestive organs

194

1.29

0.56

1.5

1.3

—

nmol/l

—

Congenital obstruction of the pelviureteric junction

1.63

0.56

1.2

—

nmol/l

—

Other forms of systemic lupus erythematosus

1.63

0.56

2.0

1.1

—

nmol/l

—

Inguinal hernia, bilateral

429

0.81

0.56

1.3

—

nmol/l

—

Use of teriflunomide

1.63

0.55

1.0

1.2

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

1.55

0.55

1.1

1.2

—

nmol/l

—

Routine general health check-up of defined subpopulation

1.54

0.55

1.3

—

Foreign body or object entering through skin

257

1.25

0.55

1.7

1.4

—

nmol/l

—

Pathological resorption of teeth

168

1.31

0.55

1.1

1.4

—

nmol/l

—

Injury of nerves at wrist and hand level

168

1.31

0.55

1.5

—

nmol/l

—

Juvenile arthritis (FINNGEN)

168

1.31

0.55

1.5

1.3

—

nmol/l

—

Streptococcal septicaemia, including avohilmo

403

1.19

0.55

1.1

1.3

—

nmol/l

—

Malignant neoplasm of bone and articular cartilage

1.59

0.54

1.2

1.3

—

Lichen simplex chronicus and prurigo

321

1.22

0.54

1.4

1.3

—

nmol/l

—

Other and unspecified degenerative diseases of nervous system

1.42

0.54

1.1

—

nmol/l

—

Toxic liver disease

1.48

0.54

1.1

1.2

—

nmol/l

—

Unspecified visual impairment (binocular)

1.48

0.54

1.2

1.3

—

Need for immunization against other single viral diseases

1.49

0.53

1.5

1.3

—

nmol/l

—

Nonalcoholic steatohepatitis

1.55

0.53

1.0

1.3

—

nmol/l

—

Benign neoplasm: Other/unspecified site

1.46

0.53

1.2

1.4

—

Hypersensitivity pneumonitis due to organic dust

1.46

0.53

1.1

1.3

—

nmol/l

—

Colitis, primary sclerosing, strict definition

1.55

0.53

1.2

—

nmol/l

—

Rheumatic fever incl heart disease

108

1.39

0.53

1.1

1.3

—

nmol/l

—

Viral conjunctivitis

1.43

0.53

1.1

1.3

—

nmol/l

—

Premature separation of placenta [abruptio placentae]

1.43

0.53

1.2

1.3

—

nmol/l

—

Drug-induced osteoporosis

1.53

0.53

1.2

1.3

—

nmol/l

—

Congenital malformations of the respiratory system

1.52

0.52

1.4

1.3

—

nmol/l

—

Other juvenile arthritis

143

1.33

0.52

1.5

1.4

—

nmol/l

—

Tuberculosis, wide

268

1.23

0.52

1.5

1.3

—

nmol/l

—

Inguinal or femoral hernia, bilateral

436

0.82

0.52

1.3

1.4

—

nmol/l

—

Unspecified dementia

372

0.82

0.52

1.2

1.3

—

nmol/l

—

Otosclerosis

369

1.20

0.52

1.7

1.3

—

nmol/l

—

Benign neoplasm: Short bones of upper limb

1.41

0.51

1.0

1.3

—

nmol/l

—

Dyshidrosis [pompholyx]

1.41

0.51

1.4

—

Use of selegiline

170

1.30

0.51

1.4

1.3

—

nmol/l

—

Macular hole

287

1.22

0.51

1.3

—

nmol/l

—

Injury of muscle and tendon at hip and thigh level

518

1.16

0.51

1.3

—

nmol/l

—

Follow-up care involving plastic surgery

191

0.73

0.51

1.1

1.3

—

nmol/l

—

Contusion of other and unspecified parts of foot

224

1.25

0.51

1.3

1.4

—

nmol/l

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.47

0.51

1.7

1.2

—

nmol/l

—

Arthropathy in ulcerative colitis

1.47

0.50

1.0

1.3

—

Other viral hepatitis, including avohilmo

288

1.22

0.50

1.4

—

nmol/l

—

Optic atrophy, wide definition

1.50

0.50

1.4

1.3

—

nmol/l

—

Benign neoplasm: Skin of lower limb, including hip

127

1.34

0.49

1.2

1.3

—

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of head

180

1.28

0.49

1.1

1.4

—

nmol/l

—

Reactive arthropathies

408

1.18

0.49

1.2

1.3

—

nmol/l

—

Disorders of orbit

207

1.26

0.49

1.0

1.3

—

nmol/l

—

Other and unspecified iridocyclitis

225

1.25

0.49

1.1

1.4

—

nmol/l

—

1.43

0.49

1.3

—

Malignant neoplasm of ureter, including Hilmo

1.57

0.49

1.0

1.2

—

nmol/l

—

Androgenic alopecia

1.57

0.49

1.0

1.2

—

Combined immunodeficiencies

1.57

0.49

1.3

—

nmol/l

—

Viral infections of central nervous system, not elsewhere classified/unspecified

1.56

0.49

1.0

1.3

—

Other abnormal auditory perceptions

1.56

0.49

1.3

1.4

—

nmol/l

—

Alzheimer’s disease (Atypical or mixed)

416

0.83

0.49

1.1

1.3

—

nmol/l

—

Subarachnoid haemorrhage

483

1.16

0.48

1.6

1.3

—

nmol/l

—

Stenosis and insufficiency of lacrimal passages

474

1.16

0.48

1.2

1.3

—

nmol/l

—

Varus deformity, not elsewhere classified

1.53

0.48

1.3

1.5

—

Obstructive hydrocephalus

1.53

0.48

1.6

1.3

—

nmol/l

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

119

1.35

0.48

1.1

1.3

—

nmol/l

—

malignant neoplasm of female genital organs, including Hilmo

118

1019

1.10

0.48

1.4

1.2

—

nmol/l

—

Intracranial and intraspinal abscess and granuloma

1.50

0.47

1.6

1.3

—

nmol/l

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

1.50

0.47

2.6

1.5

—

Type 1 diabetes, strict definition, subgroup 1

280

1.21

0.47

1.1

1.2

—

nmol/l

—

Pigmented purpuric dermatosis

1.47

0.47

1.9

1.3

—

nmol/l

—

Other meningitis

1.48

0.47

1.4

1.3

—

nmol/l

—

Malignant neoplasm of brain

155

1.29

0.47

1.4

1.3

—

nmol/l

—

Injury of muscle and tendon at ankle and foot level

111

1.36

0.47

1.1

1.4

—

nmol/l

—

Agranulocytosis

579

1.14

0.46

1.6

1.3

—

nmol/l

—

Corneal scars and opacities

120

1.34

0.46

1.3

—

nmol/l

—

Chronic lymphocytic leukaemia, helper endpoint

120

1.34

0.46

1.4

1.3

—

nmol/l

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

120

1.34

0.46

1.4

1.3

—

nmol/l

—

Chronic lymphocytic leukaemia

120

1.34

0.46

1.4

1.3

—

nmol/l

—

Vascular dementia (subcortical)

120

1.34

0.46

1.3

1.2

—

nmol/l

—

Benign neoplasm: Spinal meninges

1.44

0.46

2.1

1.3

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.43

0.46

1.3

—

nmol/l

—

Suggestive for eosinophilic asthma

430

1.16

0.46

1.2

1.4

—

nmol/l

—

Tuberculosis, wide, including avohilmo

273

1.21

0.46

1.5

1.2

—

nmol/l

—

Pneumocystosis

1.44

0.45

1.1

1.3

—

nmol/l

—

Pneumocystosis, including avohilmo

1.44

0.45

1.1

1.3

—

nmol/l

—

Iridocyclitis in diseases classified elsewhere

1.43

0.45

1.5

1.3

—

nmol/l

—

Glaucoma-related operations

255

1.22

0.45

1.3

—

nmol/l

—

Secondary malignant neoplasm of other and unspecified sites

0.59

0.45

1.4

1.3

—

Caught, crushed, jammed or pinched in or between objects

228

1.23

0.45

1.3

1.4

—

nmol/l

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

1.41

0.45

1.7

1.2

—

nmol/l

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

164

0.73

0.45

1.2

1.3

—

nmol/l

—

Motor neuron disease ALS

1.40

0.45

1.0

1.2

—

Primary angle-closure glaucoma

183

1.26

0.45

1.4

1.3

—

nmol/l

—

Rubella [German measles], including avohilmo

141

0.71

0.45

1.1

1.4

—

Post-traumatic wound infection, not elsewhere classified

112

1.34

0.44

1.3

—

nmol/l

—

Benign neoplasm: Skin of upper limb, including shoulder

1.40

0.44

1.8

1.3

—

Hepatocellular carcinoma

1.40

0.44

1.3

1.2

—

nmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

311

1.19

0.44

1.5

1.2

—

nmol/l

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

1.46

0.44

1.3

—

Osteomyelitis

256

1.21

0.44

1.3

—

nmol/l

—

Panniculitis, unspecified

1.38

0.44

1.0

1.5

—

Atypical mycobacterium lung infection

1.38

0.44

1.4

—

nmol/l

—

Late syphilis

1.38

0.44

1.1

1.2

—

nmol/l

—

Abscess of external ear

1.38

0.44

1.0

1.3

—

nmol/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

582

1.14

0.44

1.6

1.3

—

nmol/l

—

Colorectal adenocarcinoma

111

996

1.10

0.44

1.2

1.3

—

nmol/l

—

Postpartum care and examination

423

1.13

0.43

1.2

1.3

—

nmol/l

—

Other and unspecified corneal deformities and disorders

148

1.29

0.43

1.2

1.3

—

malignant neoplasm of female genital organs

103

913

1.10

0.43

1.4

1.2

—

nmol/l

—

Disorder of external ear, unspecified

157

1.28

0.43

1.2

1.3

—

nmol/l

—

Hereditary corneal dystrophies

174

0.74

0.43

1.1

1.2

—

nmol/l

—

Monoarthritis, not elsewhere classified

175

1.26

0.43

1.3

1.5

—

nmol/l

—

Muscular dystrophy

1.62

0.43

1.4

1.2

—

Pyoderma gangrenosum

1.62

0.43

5.0

1.4

—

Encephalopathy

1.62

0.43

1.4

—

Dislocation, sprain and strain of joints and ligaments of elbow

303

1.19

0.43

1.1

1.4

—

nmol/l

—

Carcinoma in situ of skin of other and unspecified parts of face

368

1.17

0.43

1.3

—

nmol/l

—

Other bullous disorders

122

1.32

0.42

1.4

1.3

—

nmol/l

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

1.57

0.42

1.0

1.1

—

nmol/l

—

Benign neoplasm: Bladder

1.57

0.42

1.8

1.4

—

Exposure to excessive natural cold

1.57

0.42

1.0

1.3

—

nmol/l

—

Chronic viral hepatitis

221

1.22

0.42

1.4

—

nmol/l

—

Benign neoplasm: Tonsil

1.41

0.42

1.6

1.3

—

Respiratory disorders in diseases classified elsewhere

1.41

0.42

1.3

1.2

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

185

1.25

0.42

1.0

1.3

—

nmol/l

—

ILD, hospital admission 2, with pulmonary infections

425

1.15

0.41

1.6

1.3

—

nmol/l

—

Other and unspecified acute skin changes due to ultraviolet radiation

1.36

0.41

1.2

—

nmol/l

—

Seronegative juvenile rheumatoid arthritis

1.38

0.41

1.1

1.2

—

nmol/l

—

Other cestode infections, including avohilmo

0.00

0.41

0.0

1.7

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.41

0.0

1.3

—

Glaucoma secondary to eye inflammation

1.52

0.41

1.0

1.3

—

Other and unspecified pemphigoid

1.52

0.41

1.0

1.5

—

nmol/l

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Metanephrine [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS